Masterful macrophages: understanding and targeting activation dysfunction in diabetic wounds

Linian Peng , Gaoxing Luo , Weifeng He

Burns & Trauma ›› 2025, Vol. 13 ›› Issue (1) : tkaf003

PDF (4545KB)
Burns & Trauma ›› 2025, Vol. 13 ›› Issue (1) :tkaf003 DOI: 10.1093/burnst/tkaf003
Review
research-article
Masterful macrophages: understanding and targeting activation dysfunction in diabetic wounds
Author information +
History +
PDF (4545KB)

Abstract

Diabetes mellitus is a group of chronic metabolic diseases worldwide that seriously threaten human health and increases the social and economic burden; underlying drivers of impaired healing include uncontrolled inflammation, repeated ischemia reperfusion injury, and neuropathy alongside infection risks. Macrophages orchestrate standard repair, exhibit sustained classical pro-inflammatory activation in diabetes, disrupting growth factor secretion, angiogenesis, and matrix regulation. Hyperglycemia mediated advanced glycation end products and reactive oxygen species heighten pattern recognition receptor stimulation, causing reduced alternative macrophage differentiation. Promising immunomodulation approaches redirecting their phenotypes to resolve inflammation and stimulate regeneration provides optimism. We discuss macrophage origination, polarization dynamics, diabetic wounds phenotypic imbalance, and critical microenvironmental disruptions perpetuating pathological function. Elucidating specific regulatory nodes upholding their activation states will inform intelligent targeting opportunities. Overall, infiltrating macrophages constitute indispensable yet amenable diabetic wound healing coordinators.

Keywords

Macrophage / Dysfunction / Diabetic / Wound healing / Mechanism

Cite this article

Download citation ▾
Linian Peng, Gaoxing Luo, Weifeng He. Masterful macrophages: understanding and targeting activation dysfunction in diabetic wounds. Burns & Trauma, 2025, 13 (1) : tkaf003 DOI:10.1093/burnst/tkaf003

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Raziyeva K, Kim Y, Zharkinbekov Z, Kassymbek K, Jimi S, Saparov A. Immunology of acute and chronic wound healing. Biomolecules. 2021; 11: 700. https://doi.org/10.3390/biom11050700.

[2]

Wang PH, Huang BS, Horng HC, Yeh CC, Chen YJ. Wound healing. J Chin Med Assoc 2018; 81: 94-101. https://doi.org/10.1016/j.jcma.2017.11.002.

[3]

A-Gonzalez N, Quintana JA, García-Silva S, Mazariegos M, González de la Aleja A, Nicolás-Ávila JA. Phagocytosis imprints heterogeneity in tissue-resident macrophages. J Exp Med 2017; 214: 1281-96. https://doi.org/10.1084/jem.20161375.

[4]

McGrath KE, Frame JM, Palis J. Early hematopoiesis and macrophage development. Semin Immunol 2015; 27: 379-87. https://doi.org/10.1016/j.smim.2016.03.013.

[5]

Ahlback A, Gentek R. Fate-mapping macrophages: from ontogeny to functions. Methods Mol Biol 2024; 2713: 11-43. https://doi.org/10.1007/978-1-0716-3437-0_2.

[6]

Kloc M, Ghobrial RM, Wosik J, Lewicka A, Lewicki S, Kubiak JZ. Macrophage functions in wound healing. J Tissue Eng Regen Med 2019; 13: 99-109.

[7]

Li M, Hou Q, Zhong L, Zhao Y, Fu X. Macrophage related chronic inflammation in non-healing wounds.Front Immunol 2021; 12: 681710. https://doi.org/10.3389/fimmu.2021.681710.

[8]

Aitcheson SM, Frentiu FD, Hurn SE, Edwards K, Murray RZ. Skin wound healing: normal macrophage function and macrophage dysfunction in diabetic wounds. Molecules. 2021; 26: 4917. https://doi.org/10.3390/molecules26164917.

[9]

Rubitschung K, Sherwood A, Crisologo AP, Bhavan K, Haley RW, Wukich DK. et al. Pathophysiology and molecular imaging of diabetic foot infections. Int J Mol Sci 2021; 22: 11552. https://doi.org/10.3390/ijms222111552.

[10]

Burgess JL, Wyant WA, Abdo Abujamra B, Kirsner RS, Jozic I. Diabetic wound-healing science.Medicina (Kaunas) 2021; 57: 1072. https://doi.org/10.3390/medicina57101072.

[11]

Pineda-Torra I, Gage M, de Juan A, Pello OM. Isolation, culture, and polarization of murine bone marrow-derived and peritoneal macrophages. Methods Mol Biol 2015; 1339: 101-9. https://doi.org/10.1007/978-1-4939-2929-0_6.

[12]

Wang N, Liang H, Zen K. Molecular mechanisms that influence the macrophage m1-m2 polarization balance. Front Immunol 2014; 5: 614. https://doi.org/10.3389/fimmu.2014.00614.

[13]

Kuijpers MJE, Heemskerk JWM, Jurk K. Molecular mechanisms of Hemostasis, thrombosis and Thrombo-inflammation. Int J Mol Sci 2022; 23: 5825. https://doi.org/10.3390/ijms23105825.

[14]

Posma JJ, Posthuma JJ, Spronk HM. Coagulation and non-coagulation effects of thrombin. J Thromb Haemost 2016; 14: 1908-16. https://doi.org/10.1111/jth.13441.

[15]

Warkentin TE.Platelet-activating anti-PF4 disorders: an overview. Semin Hematol 2022; 59: 59-71. https://doi.org/10.1053/j.seminhematol.2022.02.005.

[16]

Ottaviani E, Franchini A, Kletsas D. Platelet-derived growth factor and transforming growth factor-beta in invertebrate immune and neuroendocrine interactions: another sign of conservation in evolution. Comp Biochem Physiol C Toxicol Pharmacol 2001; 129: 295-306. https://doi.org/10.1016/S1532-0456(01)00211-3.

[17]

Phillipson M, Kubes P. The healing power of neutrophils. Trends Immunol 2019; 40: 635-47. https://doi.org/10.1016/j.it.2019.05.001.

[18]

Funes SC, Rios M, Escobar-Vera J, Kalergis AM. Implications of macrophage polarization in autoimmunity.Immunology. 2018; 154: 186-95. https://doi.org/10.1111/imm.12910.

[19]

Shrivastava R, Shukla N. Attributes of alternatively activated (M2) macrophages. Life Sci 2019; 224: 222-31. https://doi.org/10.1016/j.lfs.2019.03.062.

[20]

Bhattacharjee O, Ayyangar U, Kurbet AS, Ashok D, Raghavan S. Unraveling the ECM-immune cell crosstalk in skin diseases.Front Cell Dev Biol 2019; 7: 68. https://doi.org/10.3389/fcell.2019.00068.

[21]

Denorme F, Vanhoorelbeke K, De Meyer SF. von Willebrand factor and platelet glycoprotein Ib: A Thromboinflammatory Axis in stroke. Front Immunol 2019; 10: 2884. https://doi.org/10.3389/fimmu.2019.02884.

[22]

Smith CW. Release of α-granule contents during platelet activation. Platelets. 2022; 33: 491-502. https://doi.org/10.1080/09537104.2021.1913576.

[23]

Ryan TAJ, O’Neill LAJ. Innate immune signaling and immunothrombosis: new insights and therapeutic opportunities. Eur J Immunol 2022; 52: 1024-34. https://doi.org/10.1002/eji.202149410.

[24]

Weisel JW, Litvinov RI. Fibrin formation, structure and properties. Subcell Biochem 2017; 82: 405-56. https://doi.org/10.1007/978-3-319-49674-0_13.

[25]

He B, Niu L, Li S, Li H, Hou Y, Li A. et al. Sustainable inflammatory activation following spinal cord injury is driven by thrombin-mediated dynamic expression of astrocytic chemokines. Brain Behav Immun 2024; 116: 85-100. https://doi.org/10.1016/j.bbi.2023.11.035.

[26]

Liu ZY, Sun MX, Hua MQ, Zhang HX, Mu GY, Zhou S. et al. New perspectives on the induction and acceleration of immune-associated thrombosis by PF4 and VWF. Front Immunol 2023; 14: 1098665. https://doi.org/10.3389/fimmu.2023.1098665.

[27]

Martin P, Nunan R. Cellular and molecular mechanisms of repair in acute and chronic wound healing. Br J Dermatol 2015; 173: 370-8. https://doi.org/10.1111/bjd.13954.

[28]

Malech HL, DeLeo FR, Quinn MT. The role of neutrophils in the immune system: an overview. Methods Mol Biol 2020; 2087: 3-10. https://doi.org/10.1007/978-1-0716-0154-9_1.

[29]

Ravindran M, Khan MA, Palaniyar N. Neutrophil extracellular trap formation: physiology, pathology, and pharmacology. Biomolecules. 2019; 9: 365. https://doi.org/10.3390/biom9080365.

[30]

Abbadie C, Bhangoo S, De Koninck Y, Malcangio M, Melik-Parsadaniantz S, White FA. Chemokines and pain mechanisms. Brain Res Rev 2009; 60: 125-34. https://doi.org/10.1016/j.brainresrev.2008.12.002.

[31]

Zhao X, Di Q, Liu H, Quan J, Ling J, Zhao Z. MEF2C promotes M1 macrophage polarization and Th1 responses. Cell Mol Immunol 2022; 19: 540-53. https://doi.org/10.1038/s41423-022-00841-w.

[32]

Louiselle AE, Niemiec SM, Zgheib C, Liechty KW. Macrophage polarization and diabetic wound healing. Transl Res 2021; 236: 109-16. https://doi.org/10.1016/j.trsl.2021.05.006.

[33]

Yadav S, Dwivedi A, Tripathi A. Biology of macrophage fate decision: implication in inflammatory disorders. Cell Biol Int 2022; 46: 1539-56. https://doi.org/10.1002/cbin.11854.

[34]

Abe H, Rodgers KE, Campeau JD, Girgis W, Dizerega GS. Temporal response of leukocyte accumulation in the thoracic cavity after two types of surgical injury. J Investig Surg 1990; 3: 51-63. https://doi.org/10.3109/08941939009140336.

[35]

Barbay V, Houssari M, Mekki M, Banquet S, Edwards-Lévy F, Henry JP. et al. Role of M2-like macrophage recruitment during angiogenic growth factor therapy. Angiogenesis. 2015; 18: 191-200. https://doi.org/10.1007/s10456-014-9456-z.

[36]

Ali H, Caballero R, Dong SXM, Gajnayaka N, Vranjkovic A, Ahmed D. et al. Selective killing of human M1 macrophages by Smac mimetics alone and M2 macrophages by Smac mimetics and caspase inhibition. J Leukoc Biol 2021; 110: 693-710. https://doi.org/10.1002/JLB.4A0220-114RR.

[37]

Lamouille S, Xu J, Derynck R. Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol 2014; 15: 178-96. https://doi.org/10.1038/nrm3758.

[38]

Moretti L, Stalfort J, Barker TH, Abebayehu D. The interplay of fibroblasts, the extracellular matrix, and inflammation in scar formation. J Biol Chem 2022; 298: 101530. https://doi.org/10.1016/j.jbc.2021.101530.

[39]

Diaz C, Neubauer S, Rechenmacher F, Kessler H, Missirlis D. Recruitment of ανβ3 integrin to α5β1 integrin-induced clusters enables focal adhesion maturation and cell spreading. J Cell Sci 2020; 133: jcs232702.

[40]

Banfi A, von Degenfeld G, Gianni-Barrera R, Reginato S, Merchant MJ, McDonald DM, et al. Therapeutic angiogenesis due to balanced single-vector delivery of VEGF and PDGF-BB. FASEB J 2012; 26: 2486-97. https://doi.org/10.1096/fj.11-197400.

[41]

Arif S, Attiogbe E, Moulin VJ. Granulation tissue myofibroblasts during normal and pathological skin healing: the interaction between their secretome and the microenvironment. Wound Repair Regen 2021; 29: 563-72. https://doi.org/10.1111/wrr.12919.

[42]

Li B, Wang JH. Fibroblasts and myofibroblasts in wound healing: force generation and measurement. J Tissue Viability 2011; 20: 108-20. https://doi.org/10.1016/j.jtv.2009.11.004.

[43]

Barone N, Safran T, Vorstenbosch J, Davison PG, Cugno S, Murphy AM. Current advances in hypertrophic scar and keloid management. Semin Plast Surg 2021; 35: 145-52. https://doi.org/10.1055/s-0041-1731461.

[44]

Kim HY, Im HY, Chang HK, Jeong HD, Park JH, Kim HI. et al. Correlation between collagen type I/III ratio and scar formation in patients undergoing immediate reconstruction with the round block technique after breast-conserving surgery. Biomedicines. 2023; 11: 1089. https://doi.org/10.3390/biomedicines11041089.

[45]

Keskin ES, Keskin ER, Öztürk MB, Çakan D. The effect of MMP-1 on wound healing and scar formation. Aesth Plast Surg 2021; 45: 2973-9. https://doi.org/10.1007/s00266-021-02369-2.

[46]

Hingorani DV, Lippert CN, Crisp JL, Savariar EN, Hasselmann JPC, Kuo C. et al. Impact of MMP-2 and MMP-9 enzyme activity on wound healing, tumor growth and RACPP cleavage. PLoS One 2018; 13: e0198464. https://doi.org/10.1371/journal.pone.0198464.

[47]

Venugopal H, Hanna A, Humeres C, Frangogiannis NG. Properties and functions of fibroblasts and myofibroblasts in myocardial infarction. Cells. 2022; 11: 1386. https://doi.org/10.3390/cells11091386.

[48]

Huang J, Heng S, Zhang W, Liu Y, Xia T, Ji C. et al. Dermal extracellular matrix molecules in skin development, homeostasis, wound regeneration and diseases. Semin Cell Dev Biol 2022; 128: 137-44. https://doi.org/10.1016/j.semcdb.2022.02.027.

[49]

Dinarello CA. Overview of the IL-1 family in innate inflammation and acquired immunity. Immunol Rev 2018; 281: 8-27. https://doi.org/10.1111/imr.12621.

[50]

Fields JK, Günther S, Sundberg EJ. Structural basis of IL-1 family cytokine Signaling. Front Immunol 2019; 10: 1412. https://doi.org/10.3389/fimmu.2019.01412.

[51]

Xu J, Núñez G. The Nlrp3 inflammasome: activation and regulation. Trends Biochem Sci 2023; 48: 331-44. https://doi.org/10.1016/j.tibs.2022.10.002.

[52]

Nguyen PT, Dorman LC, Pan S, Vainchtein ID, Han RT, Nakao-Inoue H. et al. Microglial Remodeling of the extracellular matrix promotes synapse plasticity. Cell. 2020; 182: 388-403.e15. https://doi.org/10.1016/j.cell.2020.05.050.

[53]

Dinarello CA, Kaplanski G. Indeed, IL-18 is more than an inducer of IFN-γ. J Leukoc Biol 2018; 104: 237-8. https://doi.org/10.1002/JLB.CE0118-025RR.

[54]

Ma X. TNF-alpha and IL-12: a balancing act in macrophage functioning. Microbes Infect 2001; 3: 121-9. https://doi.org/10.1016/S1286-4579(00)01359-9.

[55]

Afonina IS, Beyaert R. Trabid epigenetically drives expression of IL-12 and IL-23. Nat Immunol 2016; 17: 227-8. https://doi.org/10.1038/ni.3388.

[56]

Oishi S, Takano R, Tamura S, Tani S, Iwaizumi M, Hamaya Y. et al. M2 polarization of murine peritoneal macrophages induces regulatory cytokine production and suppresses T-cell proliferation. Immunology. 2016; 149: 320-8. https://doi.org/10.1111/imm.12647.

[57]

Adib Y, Bensussan A, Michel L. Cutaneous wound healing: A review about innate immune response and current therapeutic applications. Mediat Inflamm 2022; 2022: 5344085. https://doi.org/10.1155/2022/5344085.

[58]

Marx M, Warren SL, Madri JA.pp60(c-src) modulates microvascular endothelial phenotype and in vitro angiogenesis. Exp Mol Pathol 2001; 70: 201-13. https://doi.org/10.1006/exmp.2001.2358.

[59]

Takamura N, Renaud L, da Silveira WA, Feghali-Bostwick C.PDGF promotes dermal fibroblast activation via a novel mechanism mediated by Signaling through MCHR1. Front Immunol 2021; 12: 745308. https://doi.org/10.3389/fimmu.2021.745308.

[60]

Paramasivam T, Maiti SK, Palakkara S, Rashmi MD, Manjunthaachar HV. Effect of PDGF-B gene-activated acellular matrix and mesenchymal stem cell transplantation on full thickness skin burn wound in rat model. Tissue Eng Regen Med 2021; 18: 235-51. https://doi.org/10.1007/s13770-020-00302-3.

[61]

Alexandrushkina N, Nimiritsky P, Eremichev R, Popov V, Arbatskiy M, Danilova N. et al. Cell sheets from adipose tissue MSC induce healing of pressure ulcer and prevent fibrosis via trigger effects on granulation tissue growth and vascularization. Int J Mol Sci 2020; 21: 5567. https://doi.org/10.3390/ijms21155567.

[62]

Naito H, Iba T, Takakura N. Mechanisms of new blood-vessel formation and proliferative heterogeneity of endothelial cells. Int Immunol 2020; 32: 295-305. https://doi.org/10.1093/intimm/dxaa008.

[63]

Sung DC, Chen M, Dominguez MH, Mahadevan A, Chen X, Yang J. et al. Sinusoidal and lymphatic vessel growth is controlled by reciprocal VEGF-C-CDH5 inhibition. Nat Cardiovasc Res 2022; 1: 1006-21. https://doi.org/10.1038/s44161-022-00147-0.

[64]

Pipp F, Heil M, Issbrücker K, Ziegelhoeffer T, Martin S, van den Heuvel J. VEGFR-1-selective VEGF homologue PlGF is arteriogenic: evidence for a monocyte-mediated mechanism. Circ Res 2003; 92: 378-85. https://doi.org/10.1161/01.RES.0000057997.77714.72.

[65]

Lichtman MK, Otero-Vinas M, Falanga V. Transforming growth factor beta (TGF-β) isoforms in wound healing and fibrosis. Wound Repair Regen 2016; 24: 215-22. https://doi.org/10.1111/wrr.12398.

[66]

Cheng F, Shen Y, Mohanasundaram P, Lindström M, Ivaska J, Ny T. et al. Vimentin coordinates fibroblast proliferation and keratinocyte differentiation in wound healing via TGF-β-slug signaling. Proc Natl Acad Sci USA 2016; 113: E4320-7. https://doi.org/10.1073/pnas.1519197113.

[67]

Fortunel NO, Hatzfeld JA, Monier MN, Hatzfeld A. Control of hematopoietic stem/progenitor cell fate by transforming growth factor-beta. Oncol Res 2003; 13: 445-53. https://doi.org/10.3727/096504003108748483.

[68]

Zhang L, Hu J, Meshkat BI, Liechty KW, Xu J. LncRNA MALAT1 modulates TGF-β1-induced EMT in keratinocyte. Int J Mol Sci 2021; 22: 11816. https://doi.org/10.3390/ijms222111816.

[69]

Branton MH, Kopp JB. TGF-beta and fibrosis. Microbes Infect 1999; 1: 1349-65. https://doi.org/10.1016/S1286-4579(99)00250-6.

[70]

Guan G, Xie J, Dai Y, Han H. TFPI2 suppresses the interaction of TGF-β2 pathway regulators to promote endothelial-mesenchymal transition in diabetic nephropathy. J Biol Chem 2022; 298: 101725. https://doi.org/10.1016/j.jbc.2022.101725.

[71]

Berlanga-Acosta J, Camacho-Rodríguez H, Mendoza-Marí Y, Falcón-Cama V, García-Ojalvo A, Herrera-Martínez L. Epidermal growth factor in healing diabetic foot ulcers: from gene expression to tissue healing and systemic biomarker circulation. MEDICC Rev 2020; 22: 24-31. https://doi.org/10.37757/MR2020.V22.N3.7.

[72]

Tamama K, Kawasaki H, Wells A. Epidermal growth factor (EGF) treatment on multipotential stromal cells (MSCs). Possible enhancement of therapeutic potential of MSC. J Biomed Biotechnol 2010; 2010: 795385.

[73]

Puccinelli TJ, Bertics PJ, Masters KS. Regulation of keratinocyte signaling and function via changes in epidermal growth factor presentation. Acta Biomater 2010; 6: 3415-25. https://doi.org/10.1016/j.actbio.2010.04.006.

[74]

Xie Y, Su N, Yang J, Tan Q, Huang S, Jin M. et al. Jin M. FGF/FGFR signaling in health and disease. Signal Transduct Target Ther 2020; 5: 181. https://doi.org/10.1038/s41392-020-00222-7.

[75]

Kanazawa S, Fujiwara T, Matsuzaki S, Shingaki K, Taniguchi M, Miyata S. et al. bFGF regulates PI3-kinase-Rac1-JNK pathway and promotes fibroblast migration in wound healing. PLoS One 2010; 5: e12228. https://doi.org/10.1371/journal.pone.0012228.

[76]

Xuan Y, Chi L, Tian H, Cai W, Sun C, Wang T. et al. The activation of the NF-κB-JNK pathway is independent of the PI3K-Rac1-JNK pathway involved in the bFGF-regulated human fibroblast cell migration. J Dermatol Sci 2016; 82: 28-37. https://doi.org/10.1016/j.jdermsci.2016.01.003.

[77]

Ceccarelli S, Cardinali G, Aspite N, Picardo M, Marchese C, Torrisi MR. et al. Cortactin involvement in the keratinocyte growth factor and fibroblast growth factor 10 promotion of migration and cortical actin assembly in human keratinocytes. Exp Cell Res 2007; 313: 1758-77. https://doi.org/10.1016/j.yexcr.2007.03.013.

[78]

Peng C, Chen B, Kao HK, Murphy G, Orgill DP, Guo L. Lack of FGF-7 further delays cutaneous wound healing in diabetic mice. Plast Reconstr Surg 2011; 128: 673e-84e. https://doi.org/10.1097/PRS.0b013e318230c521.

[79]

Presta M, Andrés G, Leali D, Dell’Era P, Ronca R. Inflammatory cells and chemokines sustain FGF2-induced angiogenesis. Eur Cytokine Netw 2009; 20: 39-50. https://doi.org/10.1684/ecn.2009.0155.

[80]

Bernasconi E, D’Angelo F, Michetti P, Velin D. Critical role of the GM-CSF signaling pathway in macrophage pro-repair activities. Pathobiology. 2014; 81: 183-9. https://doi.org/10.1159/000365395.

[81]

Mann A, Breuhahn K, Schirmacher P, Blessing M. Keratinocyte-derived granulocyte-macrophage colony stimulating factor accelerates wound healing: stimulation of keratinocyte proliferation, granulation tissue formation, and vascularization.J Invest Dermatol 2001; 117: 1382-90. https://doi.org/10.1046/j.0022-202x.2001.01600.x.

[82]

Mann A, Niekisch K, Schirmacher P, Blessing M. Granulocyte-macrophage colony-stimulating factor is essential for normal wound healing. J Investig Dermatol Symp Proc 2006; 11: 87-92. https://doi.org/10.1038/sj.jidsymp.5650013.

[83]

Hamilton JA. GM-CSF in inflammation. J Exp Med 2020; 217: e20190945. https://doi.org/10.1084/jem.20190945.

[84]

Lee KM, Jarnicki A, Achuthan A, Fleetwood AJ, Anderson GP, Ellson C. et al. CCL17 in inflammation and pain. J Immunol 2020; 205: 213-22. https://doi.org/10.4049/jimmunol.2000315.

[85]

Achuthan AA, Lee KMC, Hamilton JA. Targeting GM-CSF in inflammatory and autoimmune disorders. Semin Immunol 2021; 54: 101523. https://doi.org/10.1016/j.smim.2021.101523.

[86]

Ashcroft GS, Jeong MJ, Ashworth JJ, Hardman M, Jin W, Moutsopoulos N. et al. Tumor necrosis factor-alpha (TNF-α) is a therapeutic target for impaired cutaneous wound healing. Wound Repair Regen 2012; 20: 38-49. https://doi.org/10.1111/j.1524-475X.2011.00748.x.

[87]

Borghi A, Verstrepen L, Beyaert R. TRAF2 multitasking in TNF receptor-induced signaling to NF-κB, MAP kinases and cell death. Biochem Pharmacol 2016; 116: 1-10. https://doi.org/10.1016/j.bcp.2016.03.009.

[88]

Shinozaki M, Okada Y, Kitano A, Ikeda K, Saika S, Shinozaki M. Impaired cutaneous wound healing with excess granulation tissue formation in TNFalpha-null mice. Arch Dermatol Res 2009; 301: 531-7. https://doi.org/10.1007/s00403-009-0969-z.

[89]

Albanesi C, Fairchild HR, Madonna S, Scarponi C, De Pità O. Leung DY. IL-4 and IL-13 negatively regulate TNF-alpha-and IFN-gamma-induced beta-defensin expression through Stat-6, suppressor of cytokine signaling (SOCS)-1, and SOCS-3. J Immunol 2007; 179: 984-92. https://doi.org/10.4049/jimmunol.179.2.984.

[90]

Symington FW. Lymphotoxin, tumor necrosis factor, and gamma interferon are cytoStatic for normal human keratinocytes. J Invest Dermatol. 1989; 92: 798-805. https://doi.org/10.1111/1523-1747.ep12696816.

[91]

Yuan Y, Wu S, Li W, He W. A tissue-specific rhythmic recruitment pattern of leukocyte subsets. Front Immunol 2020; 11: 102. https://doi.org/10.3389/fimmu.2020.00102.

[92]

Swinehart IT, Badylak SF. Extracellular matrix bioscaffolds in tissue remodeling and morphogenesis. Dev Dyn 2016; 245: 351-60. https://doi.org/10.1002/dvdy.24379.

[93]

Karamanos NK. Extracellular matrix: key structural and functional meshwork in health and disease.FEBS J 2019; 286: 2826-9. https://doi.org/10.1111/febs.14992.

[94]

Diller RB, Tabor AJ. The role of the extracellular matrix (ECM) in wound healing: A review. Biomimetics (Basel) 2022; 7: 87. https://doi.org/10.3390/biomimetics7030087.

[95]

Michopoulou A, Montmasson M, Garnier C, Lambert E, Dayan G, Rousselle P. A novel mechanism in wound healing: laminin 332 drives MMP9/14 activity by recruiting syndecan-1 and CD44. Matrix Biol 2020; 94: 1-17. https://doi.org/10.1016/j.matbio.2020.06.004.

[96]

Gardeazabal L, Izeta A. Elastin and collagen fibres in cutaneous wound healing. Exp Dermatol 2024; 33: e15052. https://doi.org/10.1111/exd.15052.

[97]

Abbonante V, Malara A, Chrisam M, Metti S, Soprano P, Semplicini C. et al. Lack of COL6/collagen VI causes megakaryocyte dysfunction by impairing autophagy and inducing apoptosis. Autophagy. 2023; 19: 984-99. https://doi.org/10.1080/15548627.2022.2100105.

[98]

Alpoim-Moreira J, Fernandes C, Pimenta J, Bliebernicht M, Rebordão MR, Castelo-Branco P. et al. Metallopeptidades 2 and 9 genes epigenetically modulate equine endometrial fibrosis. Front Vet Sci 2022; 9: 970003. https://doi.org/10.3389/fvets.2022.970003.

[99]

Pisoschi AM, Pop A. The role of antioxidants in the chemistry of oxidative stress: A review. Eur J Med Chem 2015; 97: 55-74. https://doi.org/10.1016/j.ejmech.2015.04.040.

[100]

Bilgen F, Ural A, Kurutas EB, Bekerecioglu M. The effect of oxidative stress and Raftlin levels on wound healing.Int Wound J 2019; 16: 1178-84. https://doi.org/10.1111/iwj.13177.

[101]

Abdullah KM, Abul Qais F, Hasan H, Naseem I. Anti-diabetic study of vitamin B6 on hyperglycaemia induced protein carbonylation, DNA damage and ROS production in alloxan induced diabetic rats. Toxicol Res (Camb) 2019; 8: 568-79. https://doi.org/10.1039/C9TX00089E.

[102]

Lin CY, Lin YC, Paul CR, Hsieh DJ, Day CH, Chen RJ. et al. Isoliquiritigenin ameliorates advanced glycation end-products toxicity on renal proximal tubular epithelial cells. Environ Toxicol 2022; 37: 2096-102. https://doi.org/10.1002/tox.23553.

[103]

Kunkemoeller B, Kyriakides TR. Redox Signaling in diabetic wound healing regulates extracellular matrix deposition. Antioxid Redox Signal 2017; 27: 823-38. https://doi.org/10.1089/ars.2017.7263.

[104]

Shi XM, Xu GM, Zhang GJ, Liu JR, Wu YM, Gao LG. et al. Low-temperature plasma promotes fibroblast proliferation in wound healing by ROS-activated NF-κB Signaling pathway. Curr Med Sci 2018; 38: 107-14. https://doi.org/10.1007/s11596-018-1853-x.

[105]

Ambrozova N, Ulrichova J, Galandakova A. Models for the study of skin wound healing. The role of Nrf2 and NF-κB. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2017; 161: 1-13. https://doi.org/10.5507/bp.2016.063.

[106]

Abdel Motaal A, Salem HH, Almaghaslah D, Alsayari A, Bin Muhsinah A, Alfaifi MY. et al. Flavonol glycosides: In vitro inhibition of DPPIV, aldose reductase and combating oxidative stress are potential mechanisms for mediating the antidiabetic activity ofcleome droserifolia. Molecules. 2020; 25: 5864. https://doi.org/10.3390/molecules25245864.

[107]

Akatsuka S, Toyokuni S. Genome-wide assessment of oxidatively generated DNA damage. Free Radic Res 2012; 46: 523-30. https://doi.org/10.3109/10715762.2011.633212.

[108]

Percival SL, McCarty S, Hunt JA, Woods EJ. The effects of pH on wound healing, biofilms, and antimicrobial efficacy. Wound Repair Regen 2014; 22: 174-86. https://doi.org/10.1111/wrr.12125.

[109]

Chen YE, Fischbach MA, Belkaid Y. Skin microbiota-host interactions. Nature. 2018; 553: 427-36. https://doi.org/10.1038/nature25177.

[110]

Chen M, Knox HJ, Tang Y, Liu W, Nie L, Chan J. et al. Simultaneous photoacoustic imaging of intravascular and tissue oxygenation. Opt Lett 2019; 44: 3773-6. https://doi.org/10.1364/OL.44.003773.

[111]

Schneider LA, Korber A, Grabbe S, Dissemond J. Influence of pH on wound-healing: a new perspective for wound-therapy? Arch Dermatol Res 2007; 298: 413-20. https://doi.org/10.1007/s00403-006-0713-x.

[112]

Cacciatore I, Marinelli L. Microbial infections and wound healing: medicinal-chemistry and technological based approaches. Pharmaceutics. 2024; 16: 168. https://doi.org/10.3390/pharmaceutics16020168.

[113]

Tejada S, Batle JM, Ferrer MD, Busquets-Cortés C, Monserrat-Mesquida M, Nabavi SM. et al. Therapeutic effects of hyperbaric oxygen in the process of wound healing. Curr Pharm Des 2019; 25: 1682-93. https://doi.org/10.2174/1381612825666190703162648.

[114]

Guan Y, Niu H, Liu Z, Dang Y, Shen J, Zayed M. et al. Sustained oxygenation accelerates diabetic wound healing by promoting epithelialization and angiogenesis and decreasing inflammation. Sci Adv 2021; 7: eabj0153. https://doi.org/10.1126/sciadv.abj0153.

[115]

Locati M, Curtale G, Mantovani A.Diversity, mechanisms, and significance of macrophage plasticity. Annu Rev Pathol 2020; 15: 123-47. https://doi.org/10.1146/annurev-pathmechdis-012418-012718.

[116]

Arya AK, Tripathi R, Kumar S, Tripathi K. Recent advances on the association of apoptosis in chronic non healing diabetic wound. World J Diabetes 2014; 5: 756-62. https://doi.org/10.4239/wjd.v5.i6.756.

[117]

Pappritz K, Savvatis K, Miteva K, Kerim B, Dong F, Fechner H. Immunomodulation by adoptive regulatory T-cell transfer improves coxsackievirus B3-induced myocarditis.FASEB JPublished online June 4 2018.

[118]

Cao Q, Lin Y, Yue C, Wang Y, Quan F, Cui X. et al. IL-6 deficiency promotes colitis by recruiting Ly6Chi monocytes into inflamed colon tissues in a CCL2-CCR2-dependent manner. Eur J Pharmacol 2021; 904: 174165. https://doi.org/10.1016/j.ejphar.2021.174165.

[119]

Bonnardel J, Guilliams M. Developmental control of macrophage function. Curr Opin Immunol 2018; 50: 64-74. https://doi.org/10.1016/j.coi.2017.12.001.

[120]

Guns J, Vanherle S, Hendriks JJA, Bogie JFJ. Protein lipidation by palmitate controls macrophage function.Cells. 2022; 11: 565. https://doi.org/10.3390/cells11030565.

[121]

Yunna C, Mengru H, Lei W, Weidong C. Macrophage M1/M2 polarization. Eur J Pharmacol 2020; 877: 173090. https://doi.org/10.1016/j.ejphar.2020.173090.

[122]

Apeku E, Tantuoyir MM, Zheng R, Tanye N. Exploring the polarization of M1 and M2 macrophages in the context of skin diseases. Mol Biol Rep 2024; 51: 269. https://doi.org/10.1007/s11033-023-09014-y.

[123]

R˝oszer T. Understanding the mysterious M2 macrophage through activation markers and effector mechanisms. Mediat Inflamm 2015; 2015: 816460. https://doi.org/10.1155/2015/816460.

[124]

Atri C, Guerfali FZ, Laouini D. Role of human macrophage polarization in inflammation during infectious diseases. Int J Mol Sci 2018; 19: 1801. https://doi.org/10.3390/ijms19061801.

[125]

Liu F, Qiu H, Xue M, Zhang S, Zhang X, Xu J. et al. MSC-secreted TGF-β regulates lipopolysaccharide-stimulated macrophage M2-like polarization via the Akt/FoxO1 pathway. Stem Cell Res Ther 2019; 10: 345. https://doi.org/10.1186/s13287-019-1447-y.

[126]

Irizarry-Caro RA, McDaniel MM, Overcast GR, Jain VG, Troutman TD, Pasare C. TLR signaling adapter BCAP regulates inflammatory to reparatory macrophage transition by promoting histone lactylation. Proc Natl Acad Sci USA 2020; 117: 30628-38. https://doi.org/10.1073/pnas.2009778117.

[127]

Keophiphath M, Rouault C, Divoux A, Clément K, Lacasa D. CCL5 promotes macrophage recruitment and survival in human adipose tissue. Arterioscler Thromb Vasc Biol 2010; 30: 39-45. https://doi.org/10.1161/ATVBAHA.109.197442.

[128]

Shook B, Xiao E, Kumamoto Y, Iwasaki A, Horsley V. CD301b+ macrophages are essential for effective skin wound healing. J Invest Dermatol. 2016; 136: 1885-91. https://doi.org/10.1016/j.jid.2016.05.107.

[129]

Sheu KM, Hoffmann A. Functional hallmarks of healthy macrophage responses: their regulatory basis and disease relevance.Annu Rev Immunol 2022; 40: 295-321. https://doi.org/10.1146/annurev-immunol-101320-031555.

[130]

Biswas SK, Chittezhath M, Shalova IN, Lim JY. Macrophage polarization and plasticity in health and disease. Immunol Res 2012; 53: 11-24. https://doi.org/10.1007/s12026-012-8291-9.

[131]

Jiao Y, Zhang T, Liu M, Zhou L, Qi M, Xie X. et al. Exosomal PGE2 from M2 macrophages inhibits neutrophil recruitment and NET formation through lipid mediator class switching in sepsis. J Biomed Sci 2023; 30: 62. https://doi.org/10.1186/s12929-023-00957-9.

[132]

Liu L, Stokes JV, Tan W, Pruett SB. An optimized flow cytometry panel for classifying macrophage polarization. J Immunol Methods 2022; 511: 113378. https://doi.org/10.1016/j.jim.2022.113378.

[133]

Gao X, Lu C, Miao Y, Ren J, Cai X. Role of macrophage polarisation in skin wound healing. Int Wound J 2023; 20: 2551-62. https://doi.org/10.1111/iwj.14119.

[134]

Bártolo I, Reis RL, Marques AP, Cerqueira MT. Keratinocyte growth factor-based strategies for wound Re-epithelialization. Tissue Eng Part B Rev. 2022; 28: 665-76. https://doi.org/10.1089/ten.teb.2021.0030.

[135]

Gerhardt H, Golding M, Fruttiger M, Ruhrberg C, Lundkvist A, Abramsson A. et al. VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. J Cell Biol 2003; 161: 1163-77. https://doi.org/10.1083/jcb.200302047.

[136]

Abbasi S, Sinha S, Labit E, Rosin NL, Yoon G, Rahmani W, et al. Distinct regulatory programs control the latent regenerative potential of dermal fibroblasts during wound healing. Cell Stem Cell 2020; 27: 396-412.e6. https://doi.org/10.1016/j.stem.2020.07.008.

[137]

Wilkinson HN, Hardman MJ. Wound healing: cellular mechanisms and pathological outcomes. Open Biol 2020; 10: 200223. https://doi.org/10.1098/rsob.200223.

[138]

Téot L, Mustoe TA, Middelkoop E, Gauglitz GG. Textbook on Scar Management: State of the Art Management and Emerging Technologies. Cham (CH): Springer; 2020, https://doi.org/10.1007/978-3-030-44766-3.

[139]

Peng Y, Li L, Shang J, Zhu H, Liao J, Hong X. et al. Macrophage promotes fibroblast activation and kidney fibrosis by assembling a vitronectin-enriched microenvironment. Theranostics. 2023; 13: 3897-913. https://doi.org/10.7150/thno.85250.

[140]

Abraham LC, Dice JF, Lee K, Kaplan DL. Phagocytosis and remodeling of collagen matrices.Exp Cell Res 2007; 313: 1045-55. https://doi.org/10.1016/j.yexcr.2006.12.019.

[141]

Schappe MS, Szteyn K, Stremska ME, Mendu SK, Downs TK, Seegren P. et al. Chanzyme TRPM7 mediates the Ca2+ influx essential for lipopolysaccharide-induced toll-like receptor 4 endocytosis and macrophage activation. Immunity. 2018; 48: 59-74.e5. https://doi.org/10.1016/j.immuni.2017.11.026.

[142]

A-Gonzalez N, Hidalgo A. Nuclear receptors and clearance of apoptotic cells: stimulating the Macrophage’s appetite. Front Immunol 2014; 5:211. https://doi.org/10.3389/fimmu.2014.00211.

[143]

Amjadian S, Moradi S, Mohammadi P. The emerging therapeutic targets for scar management: genetic and epigenetic landscapes. Skin Pharmacol Physiol 2022; 35: 247-65. https://doi.org/10.1159/000524990.

[144]

Arndt L, Dokas J, Gericke M, Kutzner CE, Müller S, Jeromin F. et al. Tribbles homolog 1 deficiency modulates function and polarization of murine bone marrow-derived macrophages. J Biol Chem 2018; 293: 11527-36. https://doi.org/10.1074/jbc.RA117.000703.

[145]

Bianconi S, Leppik L, Oppermann E, Marzi I, Henrich D. Direct current electrical stimulation shifts THP-1-derived macrophage polarization towards pro-regenerative M2 phenotype. Int J Mol Sci 2024; 25: 7272. https://doi.org/10.3390/ijms25137272.

[146]

Abu-Amer Y. IL-4 abrogates osteoclastogenesis through Stat6-dependent inhibition of NF-kappaB. J Clin Invest 2001; 107: 1375-85. https://doi.org/10.1172/JCI10530.

[147]

Vogelpoel LT, Hansen IS, Rispens T, Muller FJ, van Capel TM, Turina MC. et al. Fc gamma receptor-TLR cross-talk elicits pro-inflammatory cytokine production by human M2 macrophages. Nat Commun 2014; 5: 5444. https://doi.org/10.1038/ncomms6444.

[148]

Fujii T, Mashimo M, Moriwaki Y, Misawa H, Ono S, Horiguchi K. et al. Expression and function of the cholinergic system in immune cells. Front Immunol 2017; 8: 1085. https://doi.org/10.3389/fimmu.2017.01085.

[149]

Qian Z, Yang H, Li H, Liu C, Yang L, Qu Z. et al. The cholinergic anti-inflammatory pathway attenuates the development of atherosclerosis in Apoe-/- mice through modulating macrophage functions. Biomedicines. 2021; 9: 1150. https://doi.org/10.3390/biomedicines9091150.

[150]

Aarts M, Georgilis A, Beniazza M, Beolchi P, Banito A, Carroll T. et al. Coupling shRNA screens with single-cell RNA-seq identifies a dual role for mTOR in reprogramming-induced senescence. Genes Dev 2017; 31: 2085-98. https://doi.org/10.1101/gad.297796.117.

[151]

Caputa G, Flachsmann LJ, Cameron AM. Macrophage metabolism: a wound-healing perspective. Immunol Cell Biol 2019; 97: 268-78. https://doi.org/10.1111/imcb.12237.

[152]

Ryan DG, O’Neill LAJ. Krebs cycle reborn in macrophage immunometabolism. Annu Rev Immunol 2020; 38: 289-313. https://doi.org/10.1146/annurev-immunol-081619-104850.

[153]

Allen PE, Noland RC, Martinez JJ. Rickettsia conorii survival in THP-1 macrophages involves host lipid droplet alterations and active rickettsial protein production. Cell Microbiol 2021; 23: e13390. https://doi.org/10.1111/cmi.13390.

[154]

Abdin SM, Paasch D, Kloos A, Oliveira MC, Jang MS, Ackermann M. et al. Scalable generation of functional human iPSC-derived CAR-macrophages that efficiently eradicate CD19-positive leukemia. J Immunother Cancer 2023; 11: e007705. https://doi.org/10.1136/jitc-2023-007705.

[155]

Ackermann M, Dragon AC, Lachmann N. The immunomodulatory properties of iPSC-derived antigen-presenting cells. Transfus Med Hemother 2020; 47: 444-53. https://doi.org/10.1159/000512721.

[156]

Liu B, Jiang Q, Chen R, Gao S, Xia Q, Zhu J. et al. Tacrolimus ameliorates bleomycin-induced pulmonary fibrosis by inhibiting M2 macrophage polarization via JAK2/Stat3 signaling. Int Immunopharmacol 2022; 113: 109424. https://doi.org/10.1016/j.intimp.2022.109424.

[157]

El Kasmi KC, Stenmark KR. Contribution of metabolic reprogramming to macrophage plasticity and function. Semin Immunol 2015; 27: 267-75. https://doi.org/10.1016/j.smim.2015.09.001.

[158]

Kumar S, Mittal A, Babu D, Mittal A. Herbal medicines for diabetes management and its secondary complications. Curr Diabetes Rev 2021; 17: 437-56. https://doi.org/10.2174/18756417MTExfMTQ1z.

[159]

Adiewere P, Gillis RB, Imran Jiwani S, Meal A, Shaw I, Adams GG. A systematic review and meta-analysis of patient education in preventing and reducing the incidence or recurrence of adult diabetes foot ulcers (DFU). Heliyon. 2018; 4: e00614. https://doi.org/10.1016/j.heliyon.2018.e00614.

[160]

Aagaard TV, Skou ST, Brorson S, Madsen UR. Patients’ behaviour after referral to a wound care clinic for diabetic foot ulcer care: a grounded theory study. J Wound Care 2024; 33: 432-40. https://doi.org/10.12968/jowc.2022.0265.

[161]

Davis FM, Kimball A, Boniakowski A, Gallagher K. Dysfunctional wound healing in diabetic foot ulcers: new crossroads. Curr Diab Rep 2018; 18: 2. https://doi.org/10.1007/s11892-018-0970-z.

[162]

Abd El-Khalik DM, Hafez EA, Hassan HE, Mahmoud AE, Ashour DM, Morshedy NA. Nail folds capillaries abnormalities associated with type 2 diabetes mellitus progression and correlation with diabetic retinopathy. Clin Med Insights Endocrinol Diabetes 2022; 15: 11795514221122828. https://doi.org/10.1177/11795514221122828.

[163]

Liao HZ, Liang Y, Wang Y, Liang C. Molecular pathology and therapeutic strategies of type 2 diabetes. Endocr Metab Immune Disord Drug Targets 2023; 23: 1392-9. https://doi.org/10.2174/1871530323666230320162753.

[164]

Ganesh GV, Ramkumar KM. Macrophage mediation in normal and diabetic wound healing responses. Inflamm Res 2020; 69: 347-63. https://doi.org/10.1007/s00011-020-01328-y.

[165]

Frydrych LM, Bian G, Fattahi F, Morris SB, O’Rourke RW. Lumeng CN. GM-CSF Administration improves defects in innate immunity and sepsis survival in obese diabetic mice. J Immunol 2019; 202: 931-42. https://doi.org/10.4049/jimmunol.1800713.

[166]

Chawla A, Chawla R, Jaggi S. Microvasular and macrovascular complications in diabetes mellitus: distinct or continuum? Indian J Endocrinol Metab 2016; 20: 546-51. https://doi.org/10.4103/2230-8210.183480.

[167]

Swoboda L, Held J. Impaired wound healing in diabetes. J Wound Care 2022; 31: 882-5. https://doi.org/10.12968/jowc.2022.31.10.882.

[168]

Wimmer RA, Leopoldi A, Aichinger M, Wick N, Hantusch B, Novatchkova M. et al. Human blood vessel organoids as a model of diabetic vasculopathy. Nature. 2019; 565: 505-10. https://doi.org/10.1038/s41586-018-0858-8.

[169]

Yang S, Wang S, Chen L, Wang Z, Chen J, Ni Q. et al. Neutrophil extracellular traps delay diabetic wound healing by inducing endothelial-to-mesenchymal transition via the hippo pathway. Int J Biol Sci 2023; 19: 347-61. https://doi.org/10.7150/ijbs.78046.

[170]

Hu L, Dai SC, Luan X, Chen J, Cannavicci A. Dysfunction and therapeutic potential of endothelial progenitor cells in diabetes mellitus. J Clin Med Res 2018; 10: 752-7. https://doi.org/10.14740/jocmr3581w.

[171]

Gollie JM, Sen S. Circulating endothelial progenitor and mesenchymal stromal cells as biomarkers for monitoring disease status and responses to exercise. Rev Cardiovasc Med 2022; 23: 396. https://doi.org/10.31083/j.rcm2312396.

[172]

Al SH. Macrophage phenotypes in normal and diabetic wound healing and therapeutic interventions. Cells. 2022; 11: 2430. https://doi.org/10.3390/cells11152430.

[173]

Van den Bossche J, Saraber DL. Metabolic regulation of macrophages in tissues. Cell Immunol 2018; 330: 54-9. https://doi.org/10.1016/j.cellimm.2018.01.009.

[174]

Barrett TJ, Murphy AJ, Goldberg IJ, Fisher EA. Diabetes-mediated myelopoiesis and the relationship to cardiovascular risk. Ann N Y Acad Sci 2017; 1402: 31-42. https://doi.org/10.1111/nyas.13462.

[175]

Weffort D, Adolpho LF, Souza ATP, Freitas GP, Lopes HB, Oliveira FS. et al. Normoglycemia partially recovers the disrupted osteoblast differentiation of mesenchymal stem cells induced by type 1 but not type 2 diabetes mellitus. J Cell Biochem 2023; 124: 1050-63. https://doi.org/10.1002/jcb.30434.

[176]

Horton WB, Barrett EJ. Microvascular dysfunction in diabetes mellitus and cardiometabolic disease.Endocr Rev 2021; 42: 29-55. https://doi.org/10.1210/endrev/bnaa025.

[177]

Putz Z, Tordai D, Hajdú N, Vági OE, Kempler M, Békeffy M, et al. Vitamin D in the prevention and treatment of diabetic neuropathy. Clin Ther 2022; 44: 813-23. https://doi.org/10.1016/j.clinthera.2022.03.012.

[178]

Wan R, Weissman JP, Grundman K, Lang L, Grybowski DJ, Galiano RD. Diabetic wound healing: the impact of diabetes on myofibroblast activity and its potential therapeutic treatments. Wound Repair Regen 2021; 29: 573-81. https://doi.org/10.1111/wrr.12954.

[179]

Avitabile S, Odorisio T, Madonna S, Eyerich S, Guerra L, Eyerich K. et al. Interleukin-22 promotes wound repair in diabetes by improving keratinocyte pro-healing functions. J Invest Dermatol. 2015; 135: 2862-70. https://doi.org/10.1038/jid.2015.278.

[180]

Huang X, Zha B, Zhang M, Li Y, Wu Y, Zhang R. et al. Decreased monocyte count is associated with GeStational diabetes mellitus development, macrosomia, and inflammation. J Clin Endocrinol Metab 2022; 107: 192-204. https://doi.org/10.1210/clinem/dgab657.

[181]

Willemsen L, Neele AE, van der Velden S, Prange KHM, den Toom M, van Roomen CPAA. et al. Peritoneal macrophages have an impaired immune response in obesity which can be reversed by subsequent weight loss. BMJ Open Diabetes Res Care 2019; 7: e000751. https://doi.org/10.1136/bmjdrc-2019-000751.

[182]

Beyan H, Drexhage RC, van der Heul Nieuwenhuijsen L, de Wit H, Padmos RC, Schloot NC. Monocyte gene-expression profiles associated with childhood-onset type 1 diabetes and disease risk: a study of identical twins.Diabetes. 2010; 59: 1751-5. https://doi.org/10.2337/db09-1433.

[183]

Nikolic T, Bunk M, Drexhage HA, Leenen PJ. Bone marrow precursors of nonobese diabetic mice develop into defective macrophage-like dendritic cells in vitro. J Immunol 2004; 173: 4342-51. https://doi.org/10.4049/jimmunol.173.7.4342.

[184]

Kimball A, Schaller M, Joshi A, Davis FM, denDekker A, Boniakowski A. et al. Ly6CHi blood monocyte/macrophage drive chronic inflammation and impair wound healing in diabetes mellitus. Arterioscler Thromb Vasc Biol 2018; 38: 1102-14. https://doi.org/10.1161/ATVBAHA.118.310703.

[185]

Albiero M, Poncina N, Ciciliot S, Cappellari R, Menegazzo L, Ferraro F. et al. Bone marrow macrophages contribute to diabetic stem cell Mobilopathy by producing OncoStatin M. Diabetes. 2015; 64: 2957-68. https://doi.org/10.2337/db14-1473.

[186]

Barthelmes D, Irhimeh MR, Gillies MC, Karimipour M, Zhou M, Zhu L. et al. Diabetes impairs mobilization of mouse bone marrow-derived Lin(-)/VEGF-R2(+) progenitor cells. Blood Cells Mol Dis 2013; 51: 163-73. https://doi.org/10.1016/j.bcmd.2013.05.002.

[187]

Amit I, Winter DR, Jung S. The role of the local environment and epigenetics in shaping macrophage identity and their effect on tissue homeostasis. Nat Immunol 2016; 17: 18-25. https://doi.org/10.1038/ni.3325.

[188]

Costantino S, Paneni F, Cosentino F. Targeting chromatin remodeling to prevent cardiovascular disease in diabetes. Curr Pharm Biotechnol 2015; 16: 531-43. https://doi.org/10.2174/138920101606150407113644.

[189]

Akerman I, Maestro MA, De Franco E, Grau V, Flanagan S, García-Hurtado J. Neonatal diabetes mutations disrupt a chromatin pioneering function that activates the human insulin gene. Cell Rep 2021; 35: 108981. https://doi.org/10.1016/j.celrep.2021.108981.

[190]

Bhatwadekar AD, Duan Y, Korah M, Thinschmidt JS, Hu P, Leley SP. et al. Hematopoietic stem/progenitor involvement in retinal microvascular repair during diabetes: implications for bone marrow rejuvenation. Vis Res 2017; 139: 211-20. https://doi.org/10.1016/j.visres.2017.06.016.

[191]

André C, Cota D. Coupling nutrient sensing to metabolic homoeostasis: the role of the mammalian target of rapamycin complex 1 pathway. Proc Nutr Soc 2012; 71: 502-10. https://doi.org/10.1017/S0029665112000754.

[192]

Patel S, Das A, Meshram P, Sharma A, Chowdhury A, Jariyal H. Pyruvate kinase M2 in chronic inflammations: a potpourri of crucial protein-protein interactions. Cell Biol Toxicol 2021; 37: 653-78. https://doi.org/10.1007/s10565-021-09605-0.

[193]

Hamon P, Loyher PL, Baudesson de Chanville C, Licata F, Combadière C, Boissonnas A. CX3CR1-dependent endothelial margination modulates Ly6Chigh monocyte systemic deployment upon inflammation in mice. Blood. 2017; 129: 1296-307. https://doi.org/10.1182/blood-2016-08-732164.

[194]

Czemplik M, Kulma A, Wang YF, Szopa J. Therapeutic strategies of plant-derived compounds for diabetes via regulation of monocyte chemoattractant Protein-1. Curr Med Chem 2017; 24: 1453-68. https://doi.org/10.2174/0929867324666170303162935.

[195]

Afratis NA, Sagi I. Novel approaches for extracellular matrix targeting in disease treatment. Methods Mol Biol 2019; 1952: 261-75. https://doi.org/10.1007/978-1-4939-9133-4_21.

[196]

Prinz M, Priller J.Tickets to the brain: role of CCR2 and CX3CR1 in myeloid cell entry in the CNS. J Neuroimmunol 2010; 224: 80-4. https://doi.org/10.1016/j.jneuroim.2010.05.015.

[197]

Weng J, Trinh S, Lee R, Metwale R, Sharma A. Impact of high glucose on ocular surface glycocalyx components: implications for diabetes-associated ocular surface damage. Int J Mol Sci 2022; 23: 14289. https://doi.org/10.3390/ijms232214289.

[198]

Abu El-Asrar AM, Struyf S, Mohammad G, Gouwy M, Rytinx P, Siddiquei MM. Osteoprotegerin is a new regulator of inflammation and angiogenesis in proliferative diabetic retinopathy. Invest Ophthalmol Vis Sci 2017; 58: 3189-201. https://doi.org/10.1167/iovs.16-20993.

[199]

Brun JF, Varlet-Marie E, Myzia J, Raynaud de Mauverger E, Pretorius E. Metabolic influences modulating erythrocyte deformability and eryptosis.Metabolites. 2021; 12: 4. https://doi.org/10.3390/metabo12010004.

[200]

Seetharaman S, Etienne-Manneville S. Cytoskeletal crosstalk in cell migration. Trends Cell Biol 2020; 30: 720-35. https://doi.org/10.1016/j.tcb.2020.06.004.

[201]

Kim YW, West XZ, Byzova TV.Inflammation and oxidative stress in angiogenesis and vascular disease. J Mol Med (Berl) 2013; 91: 323-8. https://doi.org/10.1007/s00109-013-1007-3.

[202]

Shamsian N. Wound bed preparation: an overview. Br J Community Nurs 2021; 26: S6-S11. https://doi.org/10.12968/bjcn.2021.26.Sup9.S6.

[203]

Abdulkadir J, Worku Y, Schreuder GM, D’Amaro J, de Vries RR, Ottenhoff TH. HLA-DR and-DQ antigens in malnutrition-related diabetes mellitus in Ethiopians: a clue to its etiology? Tissue Antigens 1989; 34: 284-9. https://doi.org/10.1111/j.1399-0039.1989.tb01744.x.

[204]

Osmundsen H, Bremer J, Pedersen JI. Metabolic aspects of peroxisomal beta-oxidation. Biochim Biophys Acta 1991; 1085: 141-58. https://doi.org/10.1016/0005-2760(91)90089-Z.

[205]

Ikeda Y, Sonoda N, Bachuluun B, Kimura S, Ogawa Y, Inoguchi T. Aberrant activation of bone marrow Ly6C high monocytes in diabetic mice contributes to impaired glucose tolerance. PLoS One 2020; 15: e0229401. https://doi.org/10.1371/journal.pone.0229401.

[206]

Abidi SM, Griffiths M, Oscier DG, Mufti GJ, Hamblin TJ. Primary myelodysplastic syndrome with complex chromosomal rearrangements in a patient with Klinefelter’s syndrome. J Med Genet 1986; 23: 183-5. https://doi.org/10.1136/jmg.23.2.183.

[207]

Ruytinx P, Proost P, Van Damme J, Struyf S. Chemokine-induced macrophage polarization in inflammatory conditions. Front Immunol 2018; 9: 1930. https://doi.org/10.3389/fimmu.2018.01930.

[208]

Ross EA, Devitt A, Johnson JR. Macrophages: the good, the bad, and the gluttony.Front Immunol 2021; 12: 708186. https://doi.org/10.3389/fimmu.2021.708186.

[209]

Mirsanei Z, Heidari N, Hazrati A, Asemani Y, Niknam B, Yousefi Z. et al. Oleuropein reduces LPS-induced inflammation via stimulating M2 macrophage polarization. Biomed Pharmacother 2023; 163: 114857. https://doi.org/10.1016/j.biopha.2023.114857.

[210]

Orecchioni M, Ghosheh Y, Pramod AB, Ley K. Macrophage polarization: different gene signatures in M1(LPS+) vs. classically and M2(LPS-) vs. alternatively activated macrophages. Front Immunol 2019; 10: 1084. https://doi.org/10.3389/fimmu.2019.01084.

[211]

Liu L, Guo H, Song A, Huang J, Zhang Y, Jin S. et al. Progranulin inhibits LPS-induced macrophage M1 polarization via NF-кB and MAPK pathways. BMC Immunol 2020; 21: 32. https://doi.org/10.1186/s12865-020-00355-y.

[212]

Lavin Y, Mortha A, Rahman A, Merad M. Regulation of macrophage development and function in peripheral tissues. Nat Rev Immunol. 2015; 15: 731-44. https://doi.org/10.1038/nri3920.

[213]

Zhao W, Ma L, Deng D, Zhang T, Han L, Xu F. et al. Xu F. M2 macrophage polarization: a potential target in pain relief. Front Immunol 2023; 14: 1243149. https://doi.org/10.3389/fimmu.2023.1243149.

[214]

Koh YC, Yang G, Lai CS, Weerawatanakorn M, Pan MH. Chemopreventive effects of phytochemicals and medicines on M1/M2 polarized macrophage role in inflammation-related diseases. Int J Mol Sci 2018; 19: 2208. https://doi.org/10.3390/ijms19082208.

[215]

Mirza RE, Fang MM, Novak ML, Urao N, Sui A, Ennis WJ. et al. Macrophage PPAR γ and impaired wound healing in type 2 diabetes. J Pathol 2015; 236: 433-44. https://doi.org/10.1002/path.4548.

[216]

Tan Q, Majewska-Szczepanik M, Zhang X, Szczepanik M, Zhou Z, Wong FS. et al. Wong FS. IRAK-M deficiency promotes the development of type 1 diabetes in NOD mice. Diabetes. 2014; 63: 2761-75. https://doi.org/10.2337/db13-1504.

[217]

Shen P, Li Q, Ma J, Tian M, Hong F, Zhai X. et al. Zhai X. IRAK-M alters the polarity of macrophages to facilitate the survival of mycobacterium tuberculosis. BMC Microbiol 2017; 17: 185. https://doi.org/10.1186/s12866-017-1095-2.

[218]

Abdel-Megeed RM, Kadry MO. Amelioration of autophagy and inflammatory signaling pathways via α-lipoic acid, burdock and bee pollen versus lipopolysaccharide-induced insulin resistance in murine model. Heliyon. 2023; 9: e15692. https://doi.org/10.1016/j.heliyon.2023.e15692.

[219]

Afanas’ev I. Signaling of reactive oxygen and nitrogen species in diabetes mellitus. Oxidative Med Cell Longev 2010; 3: 361-73. https://doi.org/10.4161/oxim.3.6.14415.

[220]

Zhou L, Zhao H, Zhao H, Meng X, Zhao Z, Xie H. et al. GBP5 exacerbates rosacea-like skin inflammation by skewing macrophage polarization towards M1 phenotype through the NF-κB signalling pathway. J Eur Acad Dermatol Venereol 2023; 37: 796-809. https://doi.org/10.1111/jdv.18725.

[221]

Abbasi S, Gharaghani S, Benvidi A, Rezaeinasab M. New insights into the efficiency of thymol synergistic effect with p-cymene in inhibiting advanced glycation end products: A multi-way analysis based on spectroscopic and electrochemical methods in combination with molecular docking study. J Pharm Biomed Anal 2018; 150: 436-51. https://doi.org/10.1016/j.jpba.2017.12.042.

[222]

Loegering DJ, Lennartz MR. Protein kinase C and toll-like receptor signaling. Enzyme Res 2011; 2011: 537821.

[223]

Kang Q, Yang C. Oxidative stress and diabetic retinopathy: molecular mechanisms, pathogenetic role and therapeutic implications. Redox Biol 2020; 37: 101799. https://doi.org/10.1016/j.redox.2020.101799.

[224]

Chio CC, Chang YH, Hsu YW, Chi KH, Lin WW. PKA-dependent activation of PKC, p38 MAPK and IKK in macrophage: implication in the induction of inducible nitric oxide synthase and interleukin-6 by dibutyryl cAMP. Cell Signal 2004; 16: 565-75. https://doi.org/10.1016/j.cellsig.2003.10.003.

[225]

Min BK, Park S, Kang HJ, Kim DW, Ham HJ, Ha CM. et al. Pyruvate dehydrogenase kinase is a metabolic checkpoint for polarization of macrophages to the M1 phenotype. Front Immunol 2019; 10: 944. https://doi.org/10.3389/fimmu.2019.00944.

[226]

Li HS, Zhou YN, Li L, Li SF, Long D, Chen XL. et al. Chen XL. HIF-1α protects against oxidative stress by directly targeting mitochondria. Redox Biol 2019; 25: 101109. https://doi.org/10.1016/j.redox.2019.101109.

[227]

Stifel U, Wolfschmitt EM, Vogt J, Wachter U, Vettorazzi S, Tews D. et al. Glucocorticoids coordinate macrophage metabolism through the regulation of the tricarboxylic acid cycle. Mol Metab 2022; 57: 101424. https://doi.org/10.1016/j.molmet.2021.101424.

[228]

Aarts SABM, Reiche ME, den Toom M, Beckers L, Gijbels MJJ, Gerdes N. et al. Macrophage CD40 plays a minor role in obesity-induced metabolic dysfunction. PLoS One 2018; 13: e0202150. https://doi.org/10.1371/journal.pone.0202150.

[229]

Kapoor N, Niu J, Saad Y, Kumar S, Sirakova T, Becerra E. et al. Transcription factors Stat6 and KLF4 implement macrophage polarization via the dual catalytic powers of MCPIP. J Immunol 2015; 194: 6011-23. https://doi.org/10.4049/jimmunol.1402797.

[230]

Chen M, Lin W, Ye R, Yi J, Zhao Z. PPAR β/δ agonist alleviates diabetic osteoporosis via regulating M1/M2 macrophage polarization. Front Cell Dev Biol. 2021; 9: 753194. https://doi.org/10.3389/fcell.2021.753194.

[231]

Xu H, Chen Y, Xie P, Lei T, Liu K, Liu X. et al. Remimazolam attenuates myocardial ischemia-reperfusion injury by inhibiting the NF-kB pathway of macrophage inflammation. Eur J Pharmacol 2024; 965: 176276. https://doi.org/10.1016/j.ejphar.2023.176276.

[232]

Adeva-Andany MM, Carneiro-Freire N, Seco-Filgueira M, Fernández-Fernández C, Mouriño-Bayolo D. Mitochondrial β-oxidation of saturated fatty acids in humans. Mitochondrion. 2019; 46: 73-90. https://doi.org/10.1016/j.mito.2018.02.009.

[233]

Basu Mallik S, Jayashree BS, Shenoy RR. Epigenetic modulation of macrophage polarization-perspectives in diabetic wounds. J Diabetes Complicat 2018; 32: 524-30. https://doi.org/10.1016/j.jdiacomp.2018.01.015.

[234]

Ackerman JE, Geary MB, Orner CA, Bawany F, Loiselle AE. Obesity/type II diabetes alters macrophage polarization resulting in a fibrotic tendon healing response. PLoS One 2017; 12: e0181127. https://doi.org/10.1371/journal.pone.0181127.

[235]

Mahmoudi A, Firouzjaei AA, Darijani F, Navashenaq JG, Taghizadeh E, Darroudi M. Effect of diabetes on efferocytosis process. Mol Biol Rep 2022; 49: 10849-63. https://doi.org/10.1007/s11033-022-07725-2.

[236]

Schilperoort M, Ngai D, Sukka SR, Avrampou K, Shi H, Tabas I. The role of efferocytosis-fueled macrophage metabolism in the resolution of inflammation. Immunol Rev 2023; 319: 65-80. https://doi.org/10.1111/imr.13214.

[237]

Zipris D, Lien E, Xie JX, Greiner DL, Mordes JP, Rossini AA. TLR activation synergizes with Kilham rat virus infection to induce diabetes in BBDR rats. J Immunol 2005; 174: 131-42. https://doi.org/10.4049/jimmunol.174.1.131.

[238]

Sepehri Z, Kiani Z, Nasiri AA, Kohan F. Toll-like receptor 2 and type 2 diabetes. Cell Mol Biol Lett 2016; 21: 2. https://doi.org/10.1186/s11658-016-0002-4.

[239]

Watanabe S, Alexander M, Misharin AV, Budinger GRS. The role of macrophages in the resolution of inflammation. J Clin Invest 2019; 129: 2619-28. https://doi.org/10.1172/JCI124615.

[240]

Yu DM, Zhao J, Lee EE, Kim D, Mahapatra R, Rose EK. et al. GLUT3 promotes macrophage signaling and function via RAS-mediated endocytosis in atopic dermatitis and wound healing. J Clin Invest 2023; 133: e170706. https://doi.org/10.1172/JCI170706.

[241]

Abbas OL, Özatik O, Gönen ZB, Ö˘güt S, Entok E, Özatik FY. et al. Prevention of burn wound progression by mesenchymal stem cell transplantation: deeper insights into underlying mechanisms. Ann Plast Surg 2018; 81: 715-24. https://doi.org/10.1097/SAP.0000000000001620.

[242]

Challa NL, Sarkar A, Kapettu S, Phanithi PB, Chakrabarti P, Parsa KVL. et al. TGS1/PIMT regulates pro-inflammatory macrophage mediated paracrine insulin resistance: crosstalk between macrophages and skeletal muscle cells. Biochim Biophys Acta Mol basis Dis 2024; 1870: 166878. https://doi.org/10.1016/j.bbadis.2023.166878.

[243]

Catrina SB, Zheng X. Hypoxia and hypoxia-inducible factors in diabetes and its complications. Diabetologia. 2021; 64: 709-16. https://doi.org/10.1007/s00125-021-05380-z.

[244]

Guyot M, Pagès G. VEGF splicing and the role of VEGF splice variants: from physiological-pathological conditions to specific pre-mRNA splicing. Methods Mol Biol 2015; 1332: 3-23. https://doi.org/10.1007/978-1-4939-2917-7_1.

[245]

Zelová H, Hoˇsek J. TNF-α signalling and inflammation: interactions between old acquaintances. Inflamm Res 2013; 62: 641-51. https://doi.org/10.1007/s00011-013-0633-0.

[246]

Shook BA, Wasko RR, Rivera-Gonzalez GC, Salazar-Gatzimas E, López-Giráldez F, Dash BC. et al. Myofibroblast proliferation and heterogeneity are supported by macrophages during skin repair. Science. 2018; 362: eaar2971. https://doi.org/10.1126/science.aar2971.

[247]

Ferracini M, Rios FJ, Pecenin M, Jancar S. Clearance of apoptotic cells by macrophages induces regulatory phenotype and involves stimulation of CD36 and platelet-activating factor receptor. Mediat Inflamm 2013; 2013: 950273. https://doi.org/10.1155/2013/950273.

[248]

Black CN, Bot M, Révész D, Scheffer PG, Penninx B. The association between three major physiological stress systems and oxidative DNA and lipid damage.Psychoneuroendocrinology. 2017; 80: 56-66. https://doi.org/10.1016/j.psyneuen.2017.03.003.

[249]

Kayagaki N, Kornfeld OS, Lee BL, Stowe IB, O’Rourke K, Li Q. NINJ1 mediates plasma membrane rupture during lytic cell death. Nature. 2021; 591: 131-6. https://doi.org/10.1038/s41586-021-03218-7.

[250]

de Freitas DV, Leal VNC, Pontillo A. The inflammasomes: crosstalk between innate immunity and hematology. Inflamm Res 2022; 71: 1403-16. https://doi.org/10.1007/s00011-022-01646-3.

[251]

Ellis S, Lin EJ, Tartar D. Immunology of wound healing. Curr Dermatol Rep 2018; 7: 350-8. https://doi.org/10.1007/s13671-018-0234-9.

[252]

Li G, Jin F, Du J, He Q, Yang B, Luo P. Macrophage-secreted TSLP and MMP9 promote bleomycin-induced pulmonary fibrosis. Toxicol Appl Pharmacol 2019; 366: 10-6. https://doi.org/10.1016/j.taap.2019.01.011.

[253]

Wang X, Khalil RA. Matrix metalloproteinases, vascular Remodeling, and vascular disease. Adv Pharmacol 2018; 81: 241-330. https://doi.org/10.1016/bs.apha.2017.08.002.

[254]

Ricard-Blum S, Baffet G, Théret N. Molecular and tissue alterations of collagens in fibrosis. Matrix Biol 2018; 68-69: 122-49. https://doi.org/10.1016/j.matbio.2018.02.004.

[255]

Zhang M, Wu Z, Salas SS, Aguilar MM, Trillos-Almanza MC, Buist-Homan M. et al. Arginase 1 expression is increased during hepatic stellate cell activation and facilitates collagen synthesis. J Cell Biochem 2023; 124: 808-17. https://doi.org/10.1002/jcb.30403.

[256]

Gajewska B, ´Sliwi´nska-Mosso´n M. Association of MMP-2 and MMP-9 polymorphisms with diabetes and pathogenesis of diabetic complications. Int J Mol Sci 2022; 23: 10571. https://doi.org/10.3390/ijms231810571.

[257]

Kauppinen A, Suuronen T, Ojala J, Kaarniranta K, Salminen A. Antagonistic crosstalk between NF-κB and SIRT1 in the regulation of inflammation and metabolic disorders. Cell Signal 2013; 25: 1939-48. https://doi.org/10.1016/j.cellsig.2013.06.007.

[258]

Russo S, Kwiatkowski M, Govorukhina N, Bischoff R, Melgert BN. Meta-inflammation and metabolic reprogramming of macrophages in diabetes and obesity: the importance of metabolites.Front Immunol 2021; 12: 746151. https://doi.org/10.3389/fimmu.2021.746151.

[259]

Kaneto H.Pancreatic β-cell glucose toxicity in type 2 diabetes mellitus. Curr Diabetes Rev 2015; 11: 2-6. https://doi.org/10.2174/1573399811666141216160217.

[260]

Abu-El-Rub E, Almahasneh F, Khasawneh RR, Alzu’bi A, Ghorab D, Almazari R. Human mesenchymal stem cells exhibit altered mitochondrial dynamics and poor survival in high glucose microenvironment.World J Stem Cells 2023; 15: 1093-103. https://doi.org/10.4252/wjsc.v15.i12.1093.

[261]

Adeva-Andany M, López-Ojén M, Funcasta-Calderón R, Ameneiros-Rodríguez E, Donapetry-García C, Vila-Altesor M. et al. Comprehensive review on lactate metabolism in human health. Mitochondrion. 2014; 17: 76-100. https://doi.org/10.1016/j.mito.2014.05.007.

[262]

Ali MA, Yasui F, Matsugo S, Konishi T. The lactate-dependent enhancement of hydroxyl radical generation by the Fenton reaction. Free Radic Res 2000; 32: 429-38. https://doi.org/10.1080/10715760000300431.

[263]

Enkler L, Szentgyörgyi V, Pennauer M, Prescianotto-Baschong C, Riezman I, Wiesyk A. et al. Arf1 coordinates fatty acid metabolism and mitochondrial homeostasis. Nat Cell Biol 2023; 25: 1157-72. https://doi.org/10.1038/s41556-023-01180-2.

[264]

Muftuoglu M, Mori MP, de Souza-Pinto NC. Formation and repair of oxidative damage in the mitochondrial DNA. Mitochondrion. 2014; 17: 164-81. https://doi.org/10.1016/j.mito.2014.03.007.

[265]

Kowalska M, Piekut T, Prendecki M, Sodel A, Kozubski W, Dorszewska J. Mitochondrial and nuclear DNA oxidative damage in physiological and pathological aging. DNA Cell Biol 2020; 39: 1410-20. https://doi.org/10.1089/dna.2019.5347.

[266]

Viola A, Munari F, Sánchez-Rodríguez R, Scolaro T, Castegna A. The metabolic signature of macrophage responses. Front Immunol 2019; 10: 1462. https://doi.org/10.3389/fimmu.2019.01462.

[267]

Acharya AB, Thakur S, Muddapur MV, Kulkarni RD. Systemic cytokines in type 2 diabetes mellitus and chronic periodontitis. Curr Diabetes Rev 2018; 14: 182-8. https://doi.org/10.2174/1573399812666161220144011.

[268]

Aslam M, Ladilov Y. Emerging role of c AMP/AMPK Signaling. Cells. 2022; 11: 308. https://doi.org/10.3390/cells11020308.

[269]

Forman HJ, Torres M. Reactive oxygen species and cell signaling: respiratory burst in macrophage signaling. Am J Respir Crit Care Med 2002; 166: S4-8. https://doi.org/10.1164/rccm.2206007.

[270]

Mohamed Adil AA, Ameenudeen S, Kumar A, Hemalatha S, Ahmed N, Ali N. et al. Emerging role of mitophagy in inflammatory diseases: cellular and molecular episodes. Curr Pharm Des 2020; 26: 485-91. https://doi.org/10.2174/1381612826666200107144810.

[271]

Starinets VS, Serov DA, Penkov NV, Belosludtseva NV, Dubinin MV, Belosludtsev KN. Alisporivir normalizes mitochondrial function of primary mouse lung endothelial cells under conditions of Hyperglycemia. Biochemistry (Mosc) 2022; 87: 605-16. https://doi.org/10.1134/S0006297922070033.

[272]

Fan P, Xie XH, Chen CH, Peng X, Zhang P, Yang C. et al. Molecular regulation mechanisms and interactions between reactive oxygen species and mitophagy. DNA Cell Biol 2019; 38: 10-22. https://doi.org/10.1089/dna.2018.4348.

[273]

Gros F, Muller S. The role of lysosomes in metabolic and autoimmune diseases. Nat Rev Nephrol 2023; 19: 366-83. https://doi.org/10.1038/s41581-023-00692-2.

[274]

Marcum JA. Nutrigenetics/nutrigenomics, personalized nutrition, and precision healthcare. Curr Nutr Rep 2020; 9: 338-45. https://doi.org/10.1007/s13668-020-00327-z.

[275]

Chen T, Dent SY. Chromatin modifiers and remodellers: regulators of cellular differentiation. Nat Rev Genet 2014; 15: 93-106. https://doi.org/10.1038/nrg3607.

[276]

Martinez FO, Gordon S, Locati M, Mantovani A. Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J Immunol 2006; 177: 7303-11. https://doi.org/10.4049/jimmunol.177.10.7303.

[277]

Cabrera-Fuentes HA, Lopez ML, McCurdy S, Fischer S, Meiler S, Baumer YL. Regulation of monocyte/macrophage polarisation by extracellular RNA. Thromb Haemost 2015; 113: 473-81. https://doi.org/10.1160/TH14-06-0507.

[278]

Linnemann AK, Krawetz SA. Maintenance of a functional higher order chromatin structure: the role of the nuclear matrix in normal and disease states. Gene Ther Mol Biol 2009; 13: 231-43.

[279]

Chacin E, Reusswig KU, Furtmeier J, Bansal P, Karl LA, Pfander B. et al. Establishment and function of chromatin organization at replication origins. Nature. 2023; 616: 836-42. https://doi.org/10.1038/s41586-023-05926-8.

[280]

Ghosh RP, Meyer BJ. Spatial Organization of Chromatin: emergence of chromatin structure during development. Annu Rev Cell Dev Biol 2021; 37: 199-232. https://doi.org/10.1146/annurev-cellbio-032321-035734.

[281]

Lin D, Xu W, Hong P, Wu C, Zhang Z, Zhang S. et al. Decoding the spatial chromatin organization and dynamic epigenetic landscapes of cells during differentiation and immune activation. Nat Commun 2022; 13: 5857. https://doi.org/10.1038/s41467-022-33558-5.

[282]

Cheng QJ, Ohta S, Sheu KM, Spreafico R, Adelaja A, Taylor B. et al. NF-κB dynamics determine the stimulus specificity of epigenomic reprogramming in macrophages. Science. 2021; 372: 1349-53. https://doi.org/10.1126/science.abc0269.

[283]

Martinez N, Vallerskog T, West K, Nunes-Alves C, Lee J, Martens GW. et al. Chromatin decondensation and T cell hyperresponsiveness in diabetes-associated hyperglycemia. J Immunol 2014; 193: 4457-68. https://doi.org/10.4049/jimmunol.1401125.

[284]

Keating ST, El-Osta A. Chromatin modifications associated with diabetes. J Cardiovasc Transl Res 2012; 5: 399-412. https://doi.org/10.1007/s12265-012-9380-9.

[285]

Sommese L, Benincasa G, Lanza M, Sorriento A, Schiano C, Lucchese R. et al. Novel epigenetic-sensitive clinical challenges both in type 1 and type 2 diabetes. J Diabetes Complicat 2018; 32: 1076-84. https://doi.org/10.1016/j.jdiacomp.2018.08.012.

[286]

Hizume K, Araki S, Hata K, Prieto E, Kundu TK, Yoshikawa K. et al. Nano-scale analyses of the chromatin decompaction induced by histone acetylation. Arch Histol Cytol 2010; 73: 149-63. https://doi.org/10.1679/aohc.73.149.

[287]

Yang J, Tian B, Brasier AR. Targeting chromatin Remodeling in inflammation and fibrosis. Adv Protein Chem Struct Biol 2017; 107: 1-36. https://doi.org/10.1016/bs.apcsb.2016.11.001.

[288]

Saeed S, Quintin J, Kerstens HH, Rao NA, Aghajanirefah A, Matarese F. et al. Epigenetic programming of monocyte-to-macrophage differentiation and trained innate immunity. Science. 2014; 345: 1251086. https://doi.org/10.1126/science.1251086.

[289]

Czimmerer Z, Nagy L. Epigenomic regulation of macrophage polarization: where do the nuclear receptors belong? Immunol Rev 2023; 317: 152-65. https://doi.org/10.1111/imr.13209.

[290]

Viksna J, Melkus G, Celms E, ˇCer¯ans K, Freivalds K, Kikusts P. et al. Topological structure analysis of chromatin interaction networks. BMC Bioinformatics 2019; 20: 618. https://doi.org/10.1186/s12859-019-3237-z.

[291]

Zhang Z, Zheng Y, Chen N, Xu C, Deng J, Feng X. et al. San Huang Xiao yan recipe modulates the HMGB1-mediated abnormal inflammatory microenvironment and ameliorates diabetic foot by activating the AMPK/Nrf2 signalling pathway. Phytomedicine. 2023; 118: 154931. https://doi.org/10.1016/j.phymed.2023.154931.

[292]

Abramowitz LK, Hanover JA. Chronically elevated O-GlcNAcylation limits nitric oxide production and deregulates specific pro-inflammatory cytokines. Front Immunol 2022; 13: 802336. https://doi.org/10.3389/fimmu.2022.802336.

[293]

Gosselin D, Link VM, Romanoski CE, Fonseca GJ, Eichenfield DZ, Spann NJ, et al. Environment drives selection and function of enhancers controlling tissue-specific macrophage identities. Cell. 2014; 159: 1327-40. https://doi.org/10.1016/j.cell.2014.11.023.

[294]

Lavin Y, Winter D, Blecher-Gonen R, David E, Keren-Shaul H, Merad M. et al. Tissue-resident macrophage enhancer landscapes are shaped by the local microenvironment. Cell. 2014; 159: 1312-26. https://doi.org/10.1016/j.cell.2014.11.018.

[295]

Murray PJ, Allen JE, Biswas SK, Fisher EA, Gilroy DW, Goerdt S. et al. Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity. 2014; 41: 14-20. https://doi.org/10.1016/j.immuni.2014.06.008.

[296]

Xue J, Schmidt SV, Sander J, Draffehn A, Krebs W, Quester I. et al. Transcriptome-based network analysis reveals a spectrum model of human macrophage activation. Immunity. 2014; 40: 274-88. https://doi.org/10.1016/j.immuni.2014.01.006.

[297]

Shapouri-Moghaddam A, Mohammadian S, Vazini H, Taghadosi M, Esmaeili SA, Mardani F. et al. Macrophage plasticity, polarization, and function in health and disease. J Cell Physiol 2018; 233: 6425-40. https://doi.org/10.1002/jcp.26429.

[298]

Faas M, Ipseiz N, Ackermann J, Culemann S, Grüneboom A, Schröder F. et al. IL-33-induced metabolic reprogramming controls the differentiation of alternatively activated macrophages and the resolution of inflammation. Immunity. 2021; 54: 2531-2546.e5. https://doi.org/10.1016/j.immuni.2021.09.010.

[299]

Mège JL, Mehraj V, Capo C. Macrophage polarization and bacterial infections. Curr Opin Infect Dis 2011; 24: 230-4. https://doi.org/10.1097/QCO.0b013e328344b73e.

[300]

Murray PJ, Wynn TA. Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol. 2011; 11: 723-37. https://doi.org/10.1038/nri3073.

[301]

Aktories P, Petry P, Glatz P, Andrieux G, Oschwald A, Botterer H. et al. An improved organotypic cell culture system to study tissue-resident macrophages ex vivo. Cell Rep Methods 2022; 2: 100260. https://doi.org/10.1016/j.crmeth.2022.100260.

[302]

Tidball JG, Villalta SA. Regulatory interactions between muscle and the immune system during muscle regeneration. Am J Physiol Regul Integr Comp Physiol 2010; 298: R1173-87. https://doi.org/10.1152/ajpregu.00735.2009.

[303]

Wynn TA, Vannella KM. Macrophages in tissue repair, regeneration, and fibrosis. Immunity. 2016; 44: 450-62. https://doi.org/10.1016/j.immuni.2016.02.015.

[304]

Bain CC, Bravo-Blas A, Scott CL, Perdiguero EG, Geissmann F, Henri S. Constant replenishment from circulating monocytes maintains the macrophage pool in the intestine of adult mice. Nat Immunol 2014; 15: 929-37. https://doi.org/10.1038/ni.2967.

[305]

Gherardini J, Uchida Y, Hardman JA, Chéret J, Mace K, Bertolini M. et al. Tissue-resident macrophages can be generated de novo in adult human skin from resident progenitor cells during substance P-mediated neurogenic inflammation ex vivo. PLoS One 2020; 15: e0227817. https://doi.org/10.1371/journal.pone.0227817.

[306]

Varol C, Mildner A, Jung S. Macrophages: development and tissue specialization. Annu Rev Immunol 2015; 33: 643-75. https://doi.org/10.1146/annurev-immunol-032414-112220.

[307]

Abe N, Nishihara T, Yorozuya T, Tanaka J. Microglia and macrophages in the pathological central and peripheral nervous systems.Cells. 2020; 9: 2132. https://doi.org/10.3390/cells9092132.

[308]

Thion MS, Low D, Silvin A, Chen J, Grisel P, Schulte-Schrepping J. et al. Microbiome influences prenatal and adult microglia in a sex-specific manner. Cell. 2018; 172: 500-516.e16. https://doi.org/10.1016/j.cell.2017.11.042.

[309]

Xu S, Tang L, Li X, Fan F, Liu Z. Immunotherapy for glioma: current management and future application.Cancer Lett 2020; 476: 1-12. https://doi.org/10.1016/j.canlet.2020.02.002.

[310]

Hussell T, Bell TJ. Alveolar macrophages: plasticity in a tissue-specific context. Nat Rev Immunol. 2014; 14: 81-93. https://doi.org/10.1038/nri3600.

[311]

Aegerter H, Lambrecht BN, Jakubzick CV. Biology of lung macrophages in health and disease. Immunity. 2022; 55: 1564-80. https://doi.org/10.1016/j.immuni.2022.08.010.

[312]

Wang Z, Wu Z, Wang H, Feng R, Wang G, Li M. et al. An immune cell atlas reveals the dynamics of human macrophage specification during prenatal development. Cell. 2023; 186: 4454-4471.e19. https://doi.org/10.1016/j.cell.2023.08.019.

[313]

Ensan S, Li A, Besla R, Degousee N, Cosme J, Roufaiel M. et al. Self-renewing resident arterial macrophages arise from embryonic CX3CR1(+) precursors and circulating monocytes immediately after birth. Nat Immunol 2016; 17: 159-68. https://doi.org/10.1038/ni.3343.

[314]

Barrett TJ.Macrophages in atherosclerosis regression. Arterioscler Thromb Vasc Biol 2020; 40: 20-33. https://doi.org/10.1161/ATVBAHA.119.312802.

[315]

Ip WKE, Hoshi N, Shouval DS, Snapper S, Medzhitov R. Anti-inflammatory effect of IL-10 mediated by metabolic reprogramming of macrophages.Science. 2017; 356: 513-9. https://doi.org/10.1126/science.aal3535.

[316]

Orihuela R, McPherson CA, Harry GJ. Microglial M1/M2 polarization and metabolic states. Br J Pharmacol 2016; 173: 649-65. https://doi.org/10.1111/bph.13139.

[317]

Hashimoto D, Chow A, Noizat C, Teo P, Beasley MB, Leboeuf M. et al. Tissue-resident macrophages self-maintain locally throughout adult life with minimal contribution from circulating monocytes. Immunity. 2013; 38: 792-804. https://doi.org/10.1016/j.immuni.2013.04.004.

[318]

Lech M, Anders HJ. Macrophages and fibrosis: how resident and infiltrating mononuclear phagocytes orchestrate all phases of tissue injury and repair. Biochim Biophys Acta 2013; 1832: 989-97. https://doi.org/10.1016/j.bbadis.2012.12.001.

[319]

Mosser DM, Hamidzadeh K, Goncalves R. Macrophages and the maintenance of homeostasis. Cell Mol Immunol. 2021; 18: 579-87. https://doi.org/10.1038/s41423-020-00541-3.

[320]

Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nat Rev Immunol 2008; 8: 958-69. https://doi.org/10.1038/nri2448.

[321]

Italiani P, Boraschi D. From monocytes to M1/M2 macrophages: phenotypical vs. functional differentiation. Front Immunol 2014; 5: 514.

[322]

Hume DA, Millard SM, Pettit AR. Macrophage heterogeneity in the single-cell era: facts and artifacts.Blood. 2023; 142: 1339-47. https://doi.org/10.1182/blood.2023020597.

[323]

Mantovani A, Biswas SK, Galdiero MR, Sica A, Locati M. Macrophage plasticity and polarization in tissue repair and remodelling. J Pathol 2013; 229: 176-85. https://doi.org/10.1002/path.4133.

[324]

Glanz V, Myasoedova VA, Sukhorukov V, Grechko A, Zhang D, Romaneneko EB. et al. Transcriptional characteristics of activated macrophages. Curr Pharm Des 2019; 25: 213-7. https://doi.org/10.2174/1381612825666190319120132.

[325]

Zhou D, Huang C, Lin Z, Zhan S, Kong L, Fang C. et al. Macrophage polarization and function with emphasis on the evolving roles of coordinated regulation of cellular signaling pathways. Cell Signal 2014; 26: 192-7. https://doi.org/10.1016/j.cellsig.2013.11.004.

[326]

Ding J, Sharon N, Bar-Joseph Z. Temporal modelling using single-cell transcriptomics. Nat Rev Genet. 2022; 23: 355-68. https://doi.org/10.1038/s41576-021-00444-7.

[327]

Rozanova S, Barkovits K, Nikolov M, Schmidt C, Urlaub H, Marcus K. Quantitative mass spectrometry-based proteomics: an overview. Methods Mol Biol 2021; 2228: 85-116. https://doi.org/10.1007/978-1-0716-1024-4_8.

[328]

Wang LX, Zhang SX, Wu HJ, Rong XL, Guo J. M2b macrophage polarization and its roles in diseases. J Leukoc Biol 2019; 106: 345-58. https://doi.org/10.1002/JLB.3RU1018-378RR.

[329]

Alsaleh NB, Aljarbou AM, Assal ME, Assiri MA, Almutairi MM, As Sobeai HM. et al. Synthesis, characterization, and toxicity assessment of zinc oxide-doped manganese oxide nanoparticles in a macrophage model. Pharmaceuticals (Basel) 2024; 17: 168. https://doi.org/10.3390/ph17020168.

[330]

Gauthier T, Chen W. Modulation of macrophage immunometabolism: A new approach to fight infections. Front Immunol 2022; 13: 780839. https://doi.org/10.3389/fimmu.2022.780839.

[331]

Cardoso M, Gaspar VM, Ferreira C, Silvestre R, Duarte IF, Mano JF. Macrophage-targeted shikonin-loaded nanogels for modulation of inflammasome activation. Nanomedicine. 2022; 42: 102548. https://doi.org/10.1016/j.nano.2022.102548.

[332]

Rehak L, Giurato L, Meloni M, Panunzi A, Manti GM, Ucciolì L. The immune-centric revolution in the diabetic foot: monocytes and lymphocytes role in wound healing and tissue regeneration-A narrative review. J Clin Med 2022; 11: 889. https://doi.org/10.3390/jcm11030889.

[333]

Burgess M, Wicks K, Gardasevic M, Mace KA. Cx3CR1 expression identifies distinct macrophage populations that contribute differentially to inflammation and repair. Immunohorizons. 2019; 3: 262-73. https://doi.org/10.4049/immunohorizons.1900038.

[334]

Geng K, Ma X, Jiang Z, Huang W, Gu J, Wang P. et al. High glucose-induced STING activation inhibits diabetic wound healing through promoting M1 polarization of macrophages. Cell Death Discov 2023; 9: 136. https://doi.org/10.1038/s41420-023-01425-x.

[335]

Peng X, He F, Mao Y, Lin Y, Fang J, Chen Y. et al. miR-146a promotes M2 macrophage polarization and accelerates diabetic wound healing by inhibiting the TLR4/NF-κB axis. J Mol Endocrinol 2022; 69: 315-27. https://doi.org/10.1530/JME-21-0019.

[336]

Li J, Jiang X, Li H, Gelinsky M, Gu Z. Tailoring materials for modulation of macrophage fate. Adv Mater 2021; 33: e2004172. https://doi.org/10.1002/adma.202004172.

[337]

Jia Y, Zhang X, Yang W, Lin C, Tao B, Deng Z. et al. A pH-responsive hyaluronic acid hydrogel for regulating the inflammation and remodeling of the ECM in diabetic wounds. J Mater Chem B 2022; 10: 2875-88. https://doi.org/10.1039/D2TB00064D.

[338]

Shahbazi MA, Sedighi M, Bauleth-Ramos T, Kant K, Correia A, Poursina N. et al. Targeted reinforcement of macrophage reprogramming toward M2 polarization by IL-4-loaded hyaluronic acid particles. ACS Omega 2018; 3: 18444-55. https://doi.org/10.1021/acsomega.8b03182.

[339]

Tan SH, Ngo ZH, Sci DB, Leavesley D, Liang K. Recent advances in the Design of Three-Dimensional and Bioprinted Scaffolds for full-thickness wound healing. Tissue Eng Part B Rev 2022; 28: 160-81. https://doi.org/10.1089/ten.teb.2020.0339.

[340]

Aavani F, Biazar E, Kheilnezhad B, Amjad F. 3D bioprinting for skin tissue regeneration: hopes and hurdles. Curr Stem Cell Res Ther 2022; 17: 415-39. https://doi.org/10.2174/1574888X17666220204144544.

[341]

Sharma A, Puri V, Kumar P, Singh I. Biopolymeric, nanopatterned, fibrous carriers for wound healing applications. Curr Pharm Des 2020; 26: 4894-908. https://doi.org/10.2174/1381612826666200701152217.

[342]

Sharma P, Kumar A, Agarwal T, Dey AD, Moghaddam FD, Rahimmanesh I. et al. Nucleic acid-based therapeutics for dermal wound healing. Int J Biol Macromol 2022; 220: 920-33. https://doi.org/10.1016/j.ijbiomac.2022.08.099.

[343]

Sebastian A, Syed F, Perry D, Balamurugan V, Colthurst J, Chaudhry IH. et al. Acceleration of cutaneous healing by electrical stimulation: degenerate electrical waveform down-regulates inflammation, up-regulates angiogenesis and advances remodeling in temporal punch biopsies in a human volunteer study. Wound Repair Regen 2011; 19: 693-708. https://doi.org/10.1111/j.1524-475X.2011.00736.x.

[344]

Luo R, Dai J, Zhang J, Li Z. Accelerated skin wound healing by electrical stimulation. Adv Healthc Mater 2021; 10: e2100557.

[345]

Subramaniam T, Fauzi MB, Lokanathan Y, Law JX. The role of calcium in wound healing. Int J Mol Sci 2021; 22: 6486. https://doi.org/10.3390/ijms22126486.

[346]

Chen L, Zhang S, Da J, Wu W, Ma F, Tang C. A systematic review and meta-analysis of efficacy and safety of negative pressure wound therapy in the treatment of diabetic foot ulcer.Ann Palliat Med 2021; 10: 10830-9. https://doi.org/10.21037/apm-21-2476.

[347]

Harrison BS, Eberli D, Lee SJ, Atala A, Yoo JJ. Oxygen producing biomaterials for tissue regeneration.Biomaterials. 2007; 28: 4628-34. https://doi.org/10.1016/j.biomaterials.2007.07.003.

[348]

Cui H, Cai J, He H, Ding S, Long Y, Lin S. Tailored chitosan/glycerol micropatterned composite dressings by 3D printing for improved wound healing. Int J Biol Macromol 2024; 255: 127952. https://doi.org/10.1016/j.ijbiomac.2023.127952.

[349]

Mostafalu P, Tamayol A, Rahimi R, Ochoa M, Khalilpour A, Kiaee G. Smart bandage for monitoring and treatment of chronic wounds. SmallPublished online July 6 2018.

[350]

Vanden Bossche J, O’Neill LA, Menon D. Macrophage immunometabolism: where are we (going)? Trends Immunol 2017; 38: 395-406. https://doi.org/10.1016/j.it.2017.03.001.

[351]

Gauthier T, Yao C, Dowdy T, Jin W, Lim YJ, Patiño LCL. TGF-β uncouples glycolysis and inflammation in macrophages and controls survival during sepsis. Sci Signal 2023; 16: eade0385. https://doi.org/10.1126/scisignal.ade0385.

[352]

Herrera V, Hsu SJ, Naveen VY, Liu WF, Haun JB. Multiplexed detection of secreted cytokines at near-molecular resolution elucidates macrophage polarization heterogeneity.Anal Chem 2022; 94: 658-68. https://doi.org/10.1021/acs.analchem.1c02222.

[353]

Liu GY, Jouandin P, Bahng RE, Perrimon N, Sabatini DM. An evolutionary mechanism to assimilate new nutrients sensors into the mTORC1 pathwayPreprint. bioRxiv. 2023. 2023.05.25.541239.

[354]

Böhme J, Martinez N, Li S, Lee A, Marzuki M, Tizazu AM. et al. Metformin enhances anti-mycobacterial responses by educating CD8+ T-cell immunometabolic circuits. Nat Commun 2020; 11: 5225. https://doi.org/10.1038/s41467-020-19095-z.

[355]

Agur T, Wedel J, Bose S, Sahankumari AGP, Goodman D, Kong SW. et al. Inhibition of mevalonate metabolism by statins augments the immunoregulatory phenotype of vascular endothelial cells and inhibits the costimulation of CD4+ T cells. Am J Transplant 2022; 22: 947-54. https://doi.org/10.1111/ajt.16872.

[356]

Abdelkader H, Fathalla Z, Seyfoddin A, Farahani M, Thrilmawithana T, Allahham A. et al. Polymeric long-acting drug delivery systems (LADDS) for treatment of chronic diseases: inserts, patches, wafers, and implants. Adv Drug Deliv Rev 2021; 177: 113957. https://doi.org/10.1016/j.addr.2021.113957.

[357]

Han SH, Chae DS, Kim SW. Dual CXCR4/IL-10 gene-edited human amniotic mesenchymal stem cells exhibit robust therapeutic properties in chronic wound healing. Int J Mol Sci 2022; 23: 15338. https://doi.org/10.3390/ijms232315338.

[358]

Rottner AK, Ye Y, Navarro-Guerrero E, Rajesh V, Pollner A, Bevacqua RJ. et al. A genome-wide CRISPR screen identifies CALCOCO2 as a regulator of beta cell function influencing type 2 diabetes risk. Nat Genet 2023; 55: 54-65. https://doi.org/10.1038/s41588-022-01261-2.

[359]

Padmakumari RG, Sherly CD, Ramesan RM. Therapeutic delivery of nucleic acids for skin wound healing.Ther Deliv 2022; 13: 339-58. https://doi.org/10.4155/tde-2022-0003.

[360]

Zhou J, Peng X, Ru Y, Xu J. Circ_0060077 knockdown alleviates high-glucose-induced cell apoptosis, oxidative stress, inflammation and fibrosis in HK-2 cells via miR-145-5p/VASN pathway. Inflammation. 2022; 45: 1911-23. https://doi.org/10.1007/s10753-022-01649-6.

[361]

Crovador R, Heim H, Cottam S, Feron K, Bhatia V, Louie F. et al. Advanced control of drug delivery for In vivo health applications via highly biocompatible self-assembled organic nanoparticles. ACS Appl Bio Mater 2021; 4: 6338-50. https://doi.org/10.1021/acscbm.1c00581.

[362]

Guillamat-Prats R. The role of MSC in wound healing, scarring and regeneration.Cells. 2021; 10: 1729. https://doi.org/10.3390/cells10071729.

[363]

Zhou C, Zhang B, Yang Y, Jiang Q, Li T, Gong J. et al. Stem cell-derived exosomes: emerging therapeutic opportunities for wound healing. Stem Cell Res Ther 2023; 14: 107. https://doi.org/10.1186/s13287-023-03345-0.

[364]

Subhan BS, Kwong J, Kuhn JF, Monas A, Sharma S, Rabbani PS. Amniotic fluid-derived multipotent stromal cells drive diabetic wound healing through modulation of macrophages. J Transl Med 2021; 19: 16. https://doi.org/10.1186/s12967-020-02674-5.

[365]

Atkinson MA, Eisenbarth GS. Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet. 2001; 358: 221-9. https://doi.org/10.1016/S0140-6736(01)05415-0.

[366]

Zamarlik MA, Pia˛tek K. Providing care for children with type 1 diabetes in kindergartens and schools. Opieka nad dzie´cmi z cukrzyca˛ typu 1 w przedszkolach i szkołach. Pediatr Endocrinol Diabetes Metab 2020; 26: 205-10.

[367]

Zamboni F, Collins MN. Cell based therapeutics in type 1 diabetes mellitus. Int J Pharm 2017; 521: 346-56. https://doi.org/10.1016/j.ijpharm.2017.02.063.

[368]

Stabler CL, Russ HA. Regulatory approval of islet transplantation for treatment of type 1 diabetes: implications and what is on the horizon. Mol Ther 2023; 31: 3107-8. https://doi.org/10.1016/j.ymthe.2023.10.011.

[369]

Li DS, Warnock GL, Tu HJ, Ao Z, He Z, Lu H. et al. Do immunotherapy and beta cell replacement play a synergistic role in the treatment of type 1 diabetes? Life Sci 2009; 85: 549-56. https://doi.org/10.1016/j.lfs.2009.08.016.

[370]

Lee CN, Lew AM, Wu L. The potential role of dendritic cells in the therapy of type 1 diabetes. Immunotherapy. 2013; 5: 591-606. https://doi.org/10.2217/imt.13.48.

[371]

Padhi S, Nayak AK, Behera A. Type II diabetes mellitus: a review on recent drug based therapeutics. Biomed Pharmacother 2020; 131: 110708. https://doi.org/10.1016/j.biopha.2020.110708.

[372]

Wei JP, Wang QH, Zheng HJ, Wei F. Research progress on non-drug treatment for blood glucose control of type 2 diabetes mellitus.Chin J Integr Med 2018; 24: 723-7. https://doi.org/10.1007/s11655-018-2844-2.

[373]

Patil PD, Mahajan UB, Patil KR, Chaudhari S, Patil CR, Agrawal YO. et al. Past and current perspective on new therapeutic targets for type-II diabetes. Drug Des Devel Ther 2017;Volume 11: 1567-83. https://doi.org/10.2147/DDDT.S133453.

[374]

Umpierrez GE, Pasquel FJ. Management of Inpatient Hyperglycemia and Diabetes in older adults. Diabetes Care 2017; 40: 509-17. https://doi.org/10.2337/dc16-0989.

[375]

LeRoith D, Biessels GJ, Braithwaite SS, Casanueva FF, Draznin B, Halter JB. et al. Treatment of diabetes in older adults: an Endocrine Society∗ clinical practice guideline. J Clin Endocrinol Metab 2019; 104: 1520-74. https://doi.org/10.1210/jc.2019-00198.

[376]

Mack LR, Tomich PG. GeStational diabetes: diagnosis, classification, and clinical care. Obstet Gynecol Clin N Am 2017; 44: 207-17. https://doi.org/10.1016/j.ogc.2017.02.002.

[377]

Kintiraki E, Goulis DG. GeStational diabetes mellitus: multidisciplinary treatment approaches.Metabolism. 2018; 86: 91-101. https://doi.org/10.1016/j.metabol.2018.03.025.

[378]

Hernandez TL, Mande A, Barbour LA. Nutrition therapy within and beyond geStational diabetes. Diabetes Res Clin Pract 2018; 145: 39-50. https://doi.org/10.1016/j.diabres.2018.04.004.

[379]

Guarnotta V, Emanuele F, Salzillo R, Bonsangue M, Amato C, Mineo MI. et al. Practical therapeutic approach in the management of diabetes mellitus secondary to Cushing’s syndrome, acromegaly and neuroendocrine tumours. Front Endocrinol (Lausanne) 2023; 14: 1248985. https://doi.org/10.3389/fendo.2023.1248985.

[380]

Resmini E, Minuto F, Colao A, Ferone D. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities. Acta Diabetol 2009; 46: 85-95. https://doi.org/10.1007/s00592-009-0112-9.

[381]

Shen Y, Tang Q, Wang J, Zhou Z, Yin Y, Zhang Y. et al. Targeting ROr α in macrophages to boost diabetic bone regeneration. Cell Prolif 2023; 56: e13474. https://doi.org/10.1111/cpr.13474.

PDF (4545KB)

0

Accesses

0

Citation

Detail

Sections
Recommended

/

〈 〉